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“What I cannot create, I do not understand” – Richard Feynman
While these famous words may stem from a physicist, they appear to have inspired 
scientists from a wider range of backgrounds: one of the key objectives of synthetic 
biologists is the design of functional proteins, a field which is said to have recently 
‘come of age’ (1). The maquette approach provides a rational way of designing 
proteins without the complexity of their natural counterparts. The Anderson group have 
employed this method to produce a variety of four-helix bundle proteins, including C45, 
a heme-binding peroxidase with impressive thermostability (2). 
This work focusses on the structural and functional impact of organic cosolvents 
on C45. The secondary structure was analysed by circular dichroism in concentrations 
of 10-80% acetonitrile, methanol, ethanol, isopropanol and TFE. A slight increase in 
helicity could be observed in up to 60% of any of the alcoholic cosolvents. In high (up 
to 80%) TFE concentrations, this was particularly pronounced, confirming the ability 
of the cosolvent to stabilise α-helices (3–5). NMR spectroscopy also suggested that 
TFE may have a stabilising effect on the enzyme. 
Further, the effect of the cosolvents on the kinetics of the reaction between C45, 
ABTS and H2O2 was investigated under limiting peroxide concentration. While the 
general trend observed was a decrease in kinetic activity, in TFE, the activity 
increased. In the highest tested cosolvent concentration of 80% TFE, the kcat showed 
a 7-fold increase compared to that in buffer. Total turnover numbers increased even 
more significantly,  by a factor of 34.  This was highly  unusual.  A smaller  increase in 
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kinetic activity upon the addition of TFE is not unprecedented (6), however not 
commonly in concentrations above 30%.  
This was investigated further using stopped flow spectrophotometry. The reaction 
did not reach saturation and no kcat or KM for H2O2 could be determined, however an 
estimate suggests the kcat/KMa/KMb increased 4-fold compared to the reaction in buffer. 
Further, it was observed that both in buffer and 80% TFE, v0/[E]0 increased 
significantly with increasing enzyme concentration. This very unusual observation was 
attributed to different levels of catalytic activity present in the dimer and monomer of 
C45. The presence of both of those was confirmed by analytical SEC as well as SEC-
SAXS.  
The mechanism of the formation of compound I, the radical intermediate in the 
catalytic cycle of heme peroxidases, was investigated using stopped-flow 
spectrophotometry of the reaction between C45 and H2O2. First, the kinetic isotope 
effect was exploited to confirm which phase of this reaction corresponded to 
compound I formation. This process was shown to be significantly faster in 80% TFE 
than buffer. This leads to the conclusion that stabilisation of the radical intermediate 
compound I plays an important role in the TFE-mediated increase in catalytic activity 
of C45.  
This work could provide a route to improving the catalytic activity of small heme 
peroxidases, which may lay the foundation of novel applications of maquette proteins, 
especially with the possibilities offered by the rapidly growing research field of enzyme 
engineering. This is especially relevant in light of the industrial interest in non-aqueous 
enzymology (7).  
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Enzymes are a class of proteins which have catalytic functions without which life 
would not be possible (8). A variety of intramolecular interactions allow them to 
spontaneously fold into their native state and carry out their functions (9–12). In nature, 
this generally occurs in aqueous solution, however, for some of their functions in vitro, 
organic media are highly advantageous, leading to the emergence of non-aqueous 
enzymology as a research field (7, 13–15). In many cases, structural stability and 
catalytic activity of enzymes decrease in organic solvents and especially in organic-
aqueous mixtures (16). 2,2,2-trifluoroethanol (TFE) has been a notable exception to 
this, with some evidence showing it can stabilise helical proteins and potentially 
increase enzymatic activity (3–5). Our understanding of the molecular processes 
underlying the interactions of proteins and enzymes in particular with TFE and other 
cosolvents is only slowly improving, being impeded to some extent by the inherent 
complexity of natural enzymes. Evolutionary naïve maquette proteins provide a more 
simplistic alternative to this (17–20). This work aims to investigate the effect of different 
cosolvents on the structure and function of C45, a de novo designed peroxidase 
binding c-type heme (2, 21). 
1.1. Historical perspective 
Humanity has utilised enzymatic fermentation by microorganisms for a long time. 
While yeast and other microorganisms have been used in the production of bread or 
alcoholic beverages since as early as 6000 BC (22), the biochemical processes behind 
1.1. Historical perspective 
2 
such fermentations have not been understood until much more recently. This 
commenced in 1833, with the discovery of catalytic function in diastases, enzymes 
which catalyse the transformation of starch into sugars (8). 44 years later, Wilhelm 
Kühne coined the term ‘enzyme’, which stems from the Greek for ‘within yeast’ (23), 
reflecting the belief that fermentation was inseparably linked with the biological 
organism hosting the enzyme. Therefore, the extraction of enzymes from yeast and 
the reproduction of their function in vitro in “cell-free fermentation”, was a significant 
breakthrough for which Eduard Buchner was awarded the 1907 Nobel Prize in 
chemistry (24, 25). 
From these pioneering studies of enzymes in fermentation, the expanding field of 
enzymology has developed and expanded vastly, as the importance of enzymes in 
biology has become increasingly clear: the majority of reactions in biological 
organisms – including humans - would be too slow to allow life without catalysis (8). A 
factor that has contributed greatly to the advancement of enzymology is the 
development of various purification and characterisation techniques for biological 
macromolecules. In particular, the progress in x-ray crystallography has had a large 
impact on the field, facilitating the investigation of the three-dimensional structure at a 
high resolution. Initial successes were the discovery of the structural elements of α-
helices and β-sheets by Linus Pauling, before entire protein structures were 
determined (26). A few years after DNA’s helical structure was discovered using x-ray 
diffraction, Kendrew and Perutz employed the technique to study protein crystals, 
resolving the complete three-dimensional structures of sperm whale myoglobin and 
horse hemoglobin (25, 27, 28). In some cases, this technique even provided invaluable 
insights into the catalytic mechanism of an enzyme through co-crystallisation with a 




Since our understanding of enzyme structure and function has evolved, a variety 
of applications has emerged. In medicine, for instance, enzymes can be used 
diagnostically in assays, for instance to mark tissue damage, monitor diabetes and for 
the early detection of cancer (23, 29–32). Additionally, enzymes have also generated 
considerable commercial interest with applications in many industries, such as the 
agriculture and food industries where they are often used to produce natural products 
on an industrial scale. The production of food additives for livestock (33), cycling of 
nutrients within soil (34), processing and refinement of sugars, dairy products or bread 
(35) require large volumes of naturally occurring enzymes. Enzymes owe their high 
demand for in vitro and in vitro applications to their highly desirable properties, such 
as stereoselectivity as well as their non-toxic and environmentally friendly nature. 
Furthermore, their high specificity and catalytic efficiency that typically increases the 
rate of a chemical reaction by a factor of 1010 – 1015 are difficult to parallel (9, 22, 36–
38). 
1.2. Protein folding  
With the exception of ribozymes, RNA-molecules with catalytic function, enzymes 
are proteins (39). Enzymes can vary greatly in structure, shape and size. Barnase, for 
example, is very small with 110 amino acid residues and a mass of 12.4 kDa whereas 
an animal fatty acid synthase monomer can weigh more than 250 kDa (40–42). 
Nonetheless, enzymes exhibit the characteristic features of protein structure.  
  Protein structure 
Proteins are polymers of α-amino acids, organic compounds that have a carboxyl 
and an amine functional group as well as an organic side chain attached to the α-
carbon (9, 10). Twenty amino acids are naturally encoded by DNA, all of which are 
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levorotatory enantiomers (except for the non-chiral glycine). The overall topology of a 
protein is defined by its primary, secondary, tertiary and quarternary structure. Primary 
structure refers to the sequence of amino acids that are connected by peptide bonds. 
The secondary structure describes well-defined, smaller scale architectural motifs 
such as α-helices and β-sheets. α-helices are commonly found in DNA binding motifs, 
such as zinc finger proteins and leucine zippers (43, 44). The tertiary structure 
encompasses the spatial arrangement of the protein in its entirety. While this can be 
a non-defined topology unique to a single protein, there are also some structures 
conserved in protein families. Examples for this include β-barrel proteins, which 
possess a structure formed by multiple β-sheets and are often found in membrane 
proteins such as porins (45). Similarly, triosephosphate isomerase (TIM) barrels 
consist of repeated eight units of α-helices surrounded by parallel β-strands and have 
a variety of catalytic functions (46, 47). Lastly, quarternary protein structure, not 
exhibited by all proteins, refers to the assembly with other proteins into homo- or 
heteromeric multi-subunit complex. An example is hemoglobin: in human adults, the 
most common type of this oxygen carrier is a heteromeric tetramer consisting of two 
α- and two β-subunits (48).  
 Levinthal’s paradox and Anfinsen’s dogma 
Protein folding refers to the conversion of unfolded amino acid sequences into a 
unique three-dimensional conformation characteristic for the specific protein. This 
process can be described as an equilibrium between the unfolded (U) and folded (F) 
proteins 
𝑈 ⇌ 𝐹 1.1 







While we have come a long way since the publication of the first structure of a 
globular protein in 1958 – with over 150,000 further structures now published in 
atomistic detail – research into the mechanisms that govern protein folding continues 
to this day (12, 49).  
In the late 1960s, Levinthal postulated that due to the large number of possible 
conformations, an unfolded polypeptide chain would take monumental amount of time 
to fold into its native state if arriving there purely by coincidence. Even a very small 
protein consisting of 101 amino acids would have 3100 possible configurations, 
assuming three rotational conformations for each of the 100 peptide bonds (50, 51). 
Even if configurational changes happen at picosecond timescales, an unbiased 
pathway sampling conformations at random would take longer than the age of the 
universe to fold correctly. Obviously, this is not how protein folding proceeds in nature, 
where it can be as fast as microseconds (12). 
In spite of this paradox, Anfinsen demonstrated that the spontaneous self-
assembly of a protein into its functionally active native state can, at least for some 
proteins, occur in solution without assistance (52–54). This indicates that the 
information about the three-dimensional structure the protein adopts is inherent to the 
amino acid chain under its normal physiological conditions, which Anfinsen named the 
“thermodynamic hypothesis” (55). The laws of thermodynamics state that a favourable 
reaction requires a negative free energy change ΔG. This is a dependent on changes 
in enthalpy H and entropy S as well as the temperature T: 
𝛥𝐺 = 𝛥𝐻 − 𝑇𝛥𝑆 1.3 
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Therefore, thermodynamically, the conformation with the lowest free energy is the 
most favourable, and if there is a unique structure at a significant energy minimum that 
is kinetically accessible, a protein will self-assemble into this conformation (Figure 
1.1). This is, however, a thermodynamic trade-off between entropic and enthalpic 
factors. With the restriction of the conformational freedom of the protein chain, there 
is a significant loss in entropy, opposing the folding process. The spontaneously 
occurring folding of proteins into a specific three-dimensional structure therefore has 
significant enthalpic benefits to overcome this (12).  
Figure 1.1: Free energy diagram of protein folding.  
There are several local minima of free energy where the protein is partially folded and a real minimum for 
the fully folded protein in its native state. The unfolded chains have the highest free energy and are thus 
the least thermodynamically favourable states. 
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 Molecular interactions governing protein folding 
As previously described by Levinthal more than half a century ago, the protein 
backbone provides some sort of restriction upon a protein’s conformational freedom. 
The different amino acids in the sequence have varying preferences and levels of 
flexibility of bond angles. Proline, for example, is significantly more rigid than glycine 
(1).  
However, there are also a multitude of non-covalent interactions between non-
neighbouring amino acids. First and foremost, the main driving force for protein folding 
is the hydrophobic effect, generally lending globular proteins a hydrophilic outer shell 
surrounding a hydrophobic centre, despite the large variation in protein topology (9, 
37). This is due to the tendency of hydrophobic residues to reduce interactions with 
polar solvents (9, 10). In their natural, aqueous environment, proteins tend to position 
their hydrophobic amino acid residues on the inside, shielded by polar amino acids 
which interact with the solvent. This is an entropically driven process resulting from 
the directional nature of hydrogen bonds. In bulk water, a single water molecule can 
take any orientation and find a hydrogen bond acceptor. When placed in the proximity 
of a non-polar group, however, the water molecule will arrange itself so that the 
hydrogen atoms will face in the direction of polar groups rather than the non-polar 
group nearby (Figure 1.2).  
This creates restrictions on the hydrogen atoms’ orientation. This lowered degree 
of freedom results in decreased entropy, which is energetically unfavourable. In order 
to limit this decrease in entropy, polar and non-polar substances spontaneously 
separate, which in the case of intracellular proteins means the formation of a 
hydrophilic shell and a hydrophobic core. This has been exploited for protein design, 
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where patterns of polar and non-polar amino acids have been used to generate 
specific structural features, such as α-helices (56).  
 
Figure 1.2: The orientations of a water molecule in bulk water and in the proximity of a non-polar, 
hydrophobic group.  
In bulk water, the orientation of the water molecule is not restricted. Near a non-polar group, however, 
the water molecule has less conformational freedom due to the inability to hydrogen bond with the non-
polar group and the resulting increased energy associated with orienting hydrogen atoms towards the 
non-polar group. This restriction in movement leads to a decrease in entropy. This is unfavourable and 
explains why proteins engulf non-polar amino acid residues within their core in aqueous solvents. Figure 
adapted from (10). 
 
While the hydrophobic effect is the primary driving force of protein folding, there 
are some further intermolecular (or, in the case of macromolecules such as proteins, 
intramolecular) forces that promote folding giving rise to the structural diversity of 
proteins. Hydrogen bonds are particularly important, especially for the formation of 
secondary structural motifs. Both α-helices and β-sheets essentially arise from specific 
repetitive patterns of hydrogen bonds, with α-helices being based on shorter range 
interactions than β-sheets (12). Interactions between aromatic groups of delocalised 
π-electrons known as ‘π-stacking’ have been shown to be of crucial importance in 
organic self-assembly such as protein folding. This has also been exploited in de novo 
designed proteins or smaller peptide structures (57, 58). As folded proteins tend to be 
tightly packed, large molecules, there are also substantial van der Waals interactions 
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(12). These include dipole-dipole interactions as well as dispersion forces. Whilst 
generally, these non-directional forces are very weak, for a tightly packed 
macromolecule with the resulting interatomic contact, they do become significant (9). 
Especially in such close proximity, electrostatic interactions between positively and 
negatively charged amino acids also play a part (12). Finally, covalent disulfide bonds 
between non-neighbouring amino acids can contribute significantly to tertiary 
structure. Insulin, for example, consists of two different chains linked by disulfide 
bonds which are important for the structure and function of the hormone (59).  
 Thermodynamic versus kinetic control of protein folding 
When Cyrus Levinthal first described the challenge of an amino acid chain 
successfully folding into a unique, native protein structure, it seemed mutually 
exclusive for a protein to reach the conformation which would be thermodynamically 
most stable and to do so in a biologically feasible timeframe (60–62). From this idea, 
the concept of thermodynamic versus kinetic control of protein folding arose. 
Thermodynamically controlled protein folding would imply that over time, the protein 
would reach the conformation at the global energy minimum, independent of the 
pathway taken to fold. In the case of thermodynamically controlled folding, no defined 
intermediate states could be observed, merely unfolded and folded protein. Kinetic 
control, on the other hand, would mean that the protein folds into the kinetically most 
accessible local minimum at a much quicker timescale. In this case, multiple populated 
transition states at local energy minima could be observed. These hypotheses 
motivated a search for intermediates, which would elucidate possible pathways much 
better.  
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For some proteins, especially small, monomeric ones, only unfolded and native 
state, but no intermediates could be observed (63–65). This means that in some cases 
proteins fold via a monophasic two-state pathway, a phenomenon known as 
cooperative folding. The first protein which was experimentally proven to unfold with 
complete cooperativity, i.e. via a two-state pathway, was barley chymotrypsin inhibitor 
2 (CI2) in 1991 (66). This is a simple protein with only 64 amino acids in its sequence, 
but for most proteins over 100 amino acid residues, the two-state model of completely 
cooperative folding does not apply (65).  
The presence of populated transition states during the folding of the majority of 
proteins suggests that protein folding is kinetically controlled in most cases. On the 
other hand, robust proteins have been designed merely on the basis of the 
computationally predicted stability of the native structure, which suggests a dominance 
of thermodynamic control (62, 67, 68). Clearly, protein folding is more convoluted and 
both kinetic and thermodynamic criteria play significant roles in protein folding.  
  Different models of protein folding 
For those proteins that do fold via the formation of transition states, a number of 
folding models have been proposed that take both kinetic and thermodynamic factors 
into account to suggest different predefined pathways by which the folding processes 
for different proteins proceeds (Figure 1.3).  
The framework model (69, 70), also known as the sequential protein folding model 
or the hierarchical model, is based on the formation of elements of secondary structure 
that is guided by local molecular interactions and occurs independent of tertiary 
structure. Elements of secondary structure grow and eventually merge, producing a 
unique, native structure (71).  
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Proposed by Karplus and Weaver in 1976 (72), the diffusion collision model 
describes the immediate formation of small hydrophobic microdomains, which 
coalesce upon diffusion mediated collision. Similar to the framework model, short 
range interactions are dominant at least in the initial steps of folding (73).  
The hydrophobic collapse model also sees hydrophobic interactions as the initial 
impetus and main driving force of protein folding , however on a larger scale (61, 74, 
75). According to this model, the unfolded molecule immediately forms the 
hydrophobic core characteristic for proteins by sequestering non-polar amino acid 
residues (76). This collapsed molecule, sometimes referred to as a ‘molten globule’, 
is partially folded and has a much smaller volume than the unfolded molecule. Within 
this special confinement, short range interactions drive the formation of secondary and 
tertiary structure.    
The nucleation condensation model contains elements of all of the previous 
models (75, 77). It proposes a mechanism whereby the rate of folding is limited by the 
formation of a weak local ‘nucleus’ that consists of some secondary and tertiary 
structure equal to those in the folded protein. The rest of the unfolded molecule then 
condenses around this template which guides the structural self-assembly of the 
protein. Larger proteins can even fold according to this model in multiple smaller 
components or modules which finally dock to form the protein in its fully folded 
conformation (67). 
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Figure 1.3:  Different proposed mechanisms for protein folding. 
The different steps involved in the formation of intermediates and the fully folded protein are highlighted 
in each case. 
 Energy landscapes 
Whilst there are proteins that fold according to each of the above-mentioned 
pathways, a number of proteins have also been shown to fold according to a mixture 
of the different models (78). It has furthermore been observed both experimentally and 
in computational simulations that depending on their environment, proteins may alter 
their folding pathways and behave according to different models (79, 80).  Therefore, 
the view of the distinct, pre-defined pathways for protein folding has been updated to 




show the different levels of free energy for the different conformations possible (81, 
82).  Each possible conformation is at a point on the map, with peaks and troughs 
showing particularly high or low energy conformations. The native structure – i.e. the 
thermodynamically most stable possible conformation - is at the global energy 
minimum, which is why this energetic surface is sometimes referred to as an “energy 
funnel”. Protein folding occurs from the edge of the funnel towards the 
thermodynamically most stable conformation. From each point on the map, a different 
energetic pathway may lead to the global energy minimum in the energy landscape’s 
centre. Every protein is considered to have a unique energy landscape for a specific 
set of environmental conditions. In a protein that exhibits cooperative folding, no 
energy barriers exist between the unfolded protein at the edge of the funnel and the 
native structure, meaning no intermediates exist. Other proteins may fold via multiple 
intermediates which are located in local energy minima. The energy landscape 
appears more rocky and uneven in this case. This theory explains why folding can 
proceed by any of the originally proposed models. Merely the energetic favourability 
of some conformations over others under a set of conditions is decisive and the 
energetic gradient on the route, rather than a specific folding pathway associated with 
any protein.  
 Figure 1.4 shows a variety of different possible energy landscapes, such as the 
one originally proposed by Levinthal (Figure 1.4 a) which is sometimes compared to 
a golf-course, where the landscape is entirely flat with the exception of the centrally 
located energy minimum. There is also the possibility of a flat landscape with a clearly 
defined path to the minimum (Figure 1.4 b), an energy landscape that appears like a 
smooth funnel where no local minima are present and protein folding would occur 
quickly and cooperatively (Figure 1.4 c). A rugged landscape with multiple kinetic 
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traps, i.e. local minima, is also shown, where proteins would fold with different 
intermediate states depending on the starting conformation (Figure 1.4 d).  
 
Figure 1.4: Different protein energy landscapes.  
a – Levinthal’s originally proposed “golf course” landscape where a protein will eventually reach its fully 
folded state (F) by sampling conformations at random. b – a clear pathway exists from an unfolded to the 
folded state. c – No defined pathway exists, but any unfolded molecule can move down an energy 
gradient to the folded state. d – There are some energetic “traps”, semi-stable transition states, and 
kinetic barriers in the folding path of any unfolded molecule. Figure adapted from (60).  
 
It is also worth noting that in many cases and especially for large proteins, folding 
is assisted by molecular chaperone proteins (83, 84). There are different classes, 
including proteins that prevent the newly synthesised amino acid chain from misfolding 
and larger, oligomeric structures that envelop unfolded proteins and assist in the 
folding process. These mechanisms are very important to further increase the rate of 
folding and prevent misfolding or aggregation in the highly crowded intracellular 
environment. Incorrectly folded proteins or aggregations can be toxic in biological 
organisms and have been shown to be linked to diseases such as Alzheimer’s disease 
(85) and cancer (86).  
  Marginal stability and the effect of temperature 
Protein folding is a delicate thermodynamic balance. Firstly, there is the favourable 
enthalpic change arising from the stabilising intramolecular interactions. Secondly, 
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there is the energetically unfavourable loss of chain entropy which opposes the 
enthalpic gain. This refers to the restriction of conformational freedom of the protein 
chain by confining it to one specific fold rather than allowing it the myriad of possible 
conformations possible in an unfolded state. For protein folding to be 
thermodynamically favourable, of course the enthalpic benefit has to outweigh the high 
entropic cost, which is estimated to be approximately 70 kcal/mol for a protein with 
100 amino acids (87, 88).  
The majority of globular proteins have been shown to be marginally stable with a 
comparably small free energy of unfolding of approximately 5-10 kcal/mol (88, 89). It 
has been suggested that such marginal stability may facilitate cellular regulation of 
protein levels and turnover, allowing efficient degradation and recycling of proteins 
(90). Furthermore, excessive stability could lock proteins in one rigid conformation and 
thereby hinder conformational changes required for protein functionality such as 
allosteric activities (91). Similarly, external hydrophobic surfaces, which are 
thermodynamically unfavourable in aqueous solutions, have been demonstrated to 
provide some assistance in protein-protein binding (92).  
Marginal stability implies that once fully folded, a change in environmental 
conditions may reverse folding. Temperature is directly related to the free energy of 
protein folding, as described in equation 1.3. Due to the loss of chain entropy 
associated with protein folding, ΔS is negative and a temperature increase will 
eventually render the folding process unfavourable. At the melting temperature TM, ΔG 
between folded and unfolded states is 0 and equal amounts of the folded and unfolded 
protein chains are present (Figure 1.5).   




Figure 1.5: Cooperative thermal denaturation of a protein.  
At the melting temperature TM (in this case 66 °C), equal amounts of folded and unfolded protein exist. 
 
When heated, non-covalent intramolecular interactions of proteins such as van 
der Waals forces and hydrogen bonds are disturbed and the flexibility of the chain 
increases (93). Some movement is important to the protein and often required for its 
function, so the native state is not entirely rigid: Even at low temperatures and in the 
crystalline state, some vibrations and rotations still take place (94). However, with 
temperature elevation, due to the strong entropic drive, these motions become 
excessive and less controlled. The protein starts to unfold which is accompanied with 
a loss of function such as catalytic activity in an enzyme.  
In line with Anfinsen’s theory that a protein chain will spontaneously fold into its 
native state, unfolding can be reversible when the solution is cooled and intramolecular 
forces reinstated, which is often observed for small proteins with simple folds (95). 
This reversible protein denaturation can occur either instantaneously, or more 
gradually, such as in multiple discrete steps, depending on the cooperativity of folding 




On the other hand, unfolding can also be irreversible, which is particularly 
observed for larger proteins with complex folds involving many long-range interactions. 
The processes leading to irreversible denaturation can be monomolecular or 
polymolecular in nature. Monomolecular denaturation may involve a protein misfolding 
by adopting a conformation at a local minimum with a kinetic barrier that is too high to 
refold into its native state. The protein may also undergo covalent changes that 
prevent refolding. Furthermore, there is the possibility of unfolded proteins to interact 
with each other, inducing polymolecular irreversible denaturation. As the protein’s 
surface becomes amphiphilic due to the hydrophobic core being exposed, it may 
aggregate with other unfolded proteins in order to increase solvent entropy, which is 
particularly likely in highly concentrated protein solutions.  
In vivo, with the exception of proteins native to thermophilic organisms, proteins 
do not normally encounter temperatures above 40 °C. However, with applications of 
proteins in vitro, for example in bioreactors, there has been significant interest in 
discovering or engineering proteins that are structurally stable and functional in higher 
temperatures (96). Enzymes, for example, are used in brewing and fermentation 
processes, in material production and as detergents which makes thermostability a 
desirable attribute of these biological catalysts (97, 98). 
Apart from in vitro applications of enzymes, research into thermostability of 
enzymes is motivated by scientific curiosity and the potential to acquire transferable 
insights into protein stability. It is also important to note that the effect of temperature 
on the catalytic activity of an enzyme is two-fold. Whilst denaturation of the protein is 
associated with loss of catalytic function, this relationship is more convoluted: 
Chemical reaction rates are correlated with temperature, meaning that an enzyme 
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catalysed reaction will occur at increasing rates with raised temperatures up to the 
point where enzyme denaturation occurs (99). 
1.3. Enzymes in organic solvents 
The chemical environment of an enzyme has a vast impact on its structure and 
function. Enzymes are highly adapted to their natural environments, where they are 
either in aqueous solutions, for instance the cytosol, or associated with cellular 
membranes. In vitro, enzymes are thus usually kept in buffered solutions that best 
mimic their natural environment. 
The aqueous nature of the solvent is often of crucial importance as demonstrated 
by hydration studies (100) as it can allow the protein greater mobility (13). A protein is 
considered to be fully hydrated when the addition of further water would only cause 
dilution, but not change the protein’s dynamics (100, 101).  The water associated with 
the protein is referred to as the hydration shell, comprising of a small number of water 
molecules which are closely coordinated in specific locations of the protein such as 
active sites, the interior or metal ions associated with the protein as well as a 
monolayer enveloping the protein surface. This hydration shell is important for the 
dynamics of the protein. It acts as a form of molecular lubricating agent, enhancing the 
protein’s conformational flexibility and allowing it to achieve its active conformation 
(13, 101–103). Furthermore, as discussed previously, the hydrophobic effect plays a 
key role in protein folding and in a non-aqueous setting, the formation of a hydrophobic 
core would be less favourable. This would strongly decrease protein stability.   
With the important role of water molecules to proteins, which have, after all, 
evolved in aqueous environments, it is understandable the idea of non-aqueous 




taken place in water-based buffering solutions (16, 104). In fact, Christian Anfinsen, 
1972 Nobel laureate for his discoveries regarding the folding of amino acid chains into 
native proteins, said in his prize acceptance speech: “A protein molecule only makes 
stable, structural sense when it exists under conditions similar to [the] physiological 
state” (55).  
However, there is significant motivation to use enzymes in non-aqueous media: 
firstly, there is the inherent scientific curiosity, with the possibility of gaining some 
valuable insights into enzymatic mechanisms and molecular dynamics. There is also 
some indication that there may be properties, such as specificity and selectivity, that 
can be modulated and controlled by finetuning the solvent in which enzymatic 
reactions take place (105–107). This has been shown for substrate selectivity (106, 
108, 109), chemo- and regioselectivity (110, 111) and stereospecificity (112–115). It 
has been proposed that these properties may be related to the changed energetics of 
substrate binding in solvent: whilst the interactions between the substrate and the 
enzyme are likely unchanged if the protein retained its conformation, the exclusion of 
solvent molecules from the binding site will be associated with a different desolvation 
energy (106, 109).   
Additionally, the prevention of contamination by microbial growths facilitates 
storage of enzymes in non-aqueous media (105). Most importantly, however, a much 
greater range of organic substrates insoluble in water could be used in biocatalytic 
reactions as the majority takes place in non-aqueous media. Furthermore, water 
decomposes some organic reagents or can promote side reactions (116). For these 
reasons, significant efforts have gone into the use of enzymes in organic solvents, a 
field which has grown significantly since the 1980s (15, 117–119).  
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  Challenges in non-aqueous enzymology 
In general, enzymes are less active in anhydrous organic solvents for a multitude 
of reasons, although they are not necessarily insurmountable (13, 16). Early work by 
Klibanov and colleagues showed that two proteases are 104-105 times more 
catalytically efficient in water than in octane which was the non-aqueous solvent they 
found to be the most pertinent to catalysis (14). Whilst significantly worse than in water, 
the enzyme remains catalytically active, with a rate acceleration of 1011 compared to 
that of the reaction in the absence of enzyme. One of the problems of the use of 
enzymes in organic solvents is the lower solubility of enzymes in organic solvents 
which leads to the formation of suspensions of enzymes in solvent, rather than 
solutions, as in the case of aqueous media (16, 120). Therefore, inaccessibility of 
enzymatic centres and diffusional limitations of the reaction substrates may hinder 
enzymatic activity, which is not uncommon in heterogeneous catalysis. Theoretical 
analysis suggested this may be a contributor. However, spectrophotometric titration of 
enzyme active centres with 1-trans-cinnamoyl imidazole (14) showed it can only be 
responsible for a small fraction of the activity loss in organic solvents (16, 121). There 
are, however, strategies to overcome the solubility hurdle: some groups have worked 
in inverse micelles, where the enzyme is separated from the organic phase in small 
aqueous pools. Unsurprisingly, the enzymes’ observed structural and catalytic 
properties were not significantly different from those in aqueous solutions and 
technically, the reaction medium is not neat organic solvent (14, 122, 123). The other 
possibility is to dehydrate the protein entirely and resuspend the dry protein powder. 
This is usually achieved by means of lyophilisation, a process also known as freeze-
drying, during which water is removed from frozen protein samples via sublimation and 
desorption (105, 124). With the importance of a stable temperature and hydration of 
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proteins, both freezing and drying are processes that are potentially denaturing of 
proteins. Generally, the structural motif of β-sheets appears to be more resilient to 
lyophilisation-induced denaturation than α-helices (105). Whilst protein denaturation 
by exposure to anhydrous organic solvents was one of the biggest hypothesised 
problems associated with non-aqueous enzymology, experimental data (16) show that 
denaturation is almost exclusively associated with lyophilisation rather than the 
subsequent resuspension. This denaturation can often prevented with the use of 
lyoprotectants, such as inorganic salts (especially potassium chloride) (125), crown 
ethers (126) or sugars (127). Another form of protecting the enzyme’s conformation 
during lyophilisation is the use of detergents or other amphiphilic molecules to form 
complexes with enzymes (128). These lyoprotection strategies have enhanced the 
activity of enzymes in organic solvents by up to four orders of magnitudes (16). An 
important aspect of lyophilisation is that it needs to be done in an aqueous solution of 
optimum pH for catalysis. Klibanov et al. found that the catalytic behaviour of 
resuspended enzymes mirrors that displayed at the pH of the last aqueous solution in 
which they were dissolved, a phenomenon sometimes referred to as ‘pH memory’ (14–
16, 129). This is related to the observation that enzymes’ ionogenic groups, such as 
charged amino acids, are less able to change their ionisation state in organic solvents 
than in aqueous ones (14). Furthermore, in non-aqueous solutions, enzymes have 
less conformational freedom for two reasons: firstly, the lower dielectric constants of 
non-aqueous solvents enhance intramolecular electrostatic interactions and thereby 
rigidify enzymes (130). Secondly, the lubricating properties of the hydration shell allow 
enzymes some mobility. Even during lyophilisation and resuspension in anhydrous 
solvents, some of the tightly bound water molecules are retained. In non-polar 
solvents, this is less likely to be stripped from the enzyme, which explains the observed 
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positive correlation between solvent hydrophobicity and enzymatic activity (131). 
Whilst this property is initially a challenge for non-aqueous enzyme catalysis, it has 
also been exploited to increase enzyme efficiency in anhydrous solvents by locking 
enzymes in their active conformation through lyophilisation of an enzyme-ligand 
complex as opposed to the enzyme by itself. Subtilisin, for instance, is up to two orders 
of magnitude as active in anhydrous solvents when lyophilised in the presence of 
competitive inhibitors (which are subsequently extracted) than in the absence of these 
ligands (132, 133). The principle of this ‘molecular memory’ is visualised in Figure 1.6 
(13). 
 
Figure 1.6: Diagram visualising the molecular memory effect of enzymes in anhydrous solvents owed to 
their higher rigidity.  
 
A further obstacle to enzyme-mediated catalysis in non-polar organic solvents lies 
in the thermodynamics of substrate binding. The active centre of many enzymes is 
hydrophobic, and these enzymes tend to work most efficiently with hydrophobic 




favourable in aqueous or polar solvents than in hydrophobic solvents, where the 
ground state is stabilised. This higher desolvation energy increases the net binding 
energy which is a strong thermodynamic contributor to enzyme catalysis (16, 134). In 
one experiment with crystalline cross-linked subtilisin, the lowered desolvation energy 
in acetonitrile as opposed to water led to a kcat/KM reduction by a factor of 100 (135).  
It is also worth noting that this applies only to anhydrous solvents. With the addition 
of very small amounts of water, this can be curbed significantly: in one case, in solvent 
with 0.5% water, the activity is approximately a quarter of that in aqueous solution 
(131) showing the important distinction between the use of neat organic solvents 
versus mixtures. Mixtures of organic solvents with aqueous buffers – apart from the 
aforementioned work in micelles - allow a smaller range of solvents, namely those that 
are miscible with water. Less attention has been paid to work of enzymes in aqueous-
organic mixtures with more than 10% aqueous solution. However, for a few enzymes, 
some rate enhancements have been observed in cosolvent concentrations of up to 
20% without any notable structural changes being observed (136), while others 
suggest organic-aqueous mixtures could be detrimental to enzyme structure and 
function (13).   
In order to circumvent any possible complications arising from lyophilisation and 
to potentially observe a more gradual change in enzyme structure and function, the 
work presented herein investigates the structure and function of a de novo enzyme in 
mixtures of aqueous buffer with a variety of solvents. There are some important 
distinctions between various organic solvents, the first one being different polarities 
which in turn effect different levels of miscibility with water. Secondly, solvents can be 
divided into protic and aprotic, conveying a substance’s ability – or inability – to act as 
hydrogen bond donors. Typically, protic solvents are much better at dissolving salts 
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than aprotic solvents, making them more suitable for enzymology work in organic 
aqueous mixtures (137). Depending on the stability of the solvent, a result of 
intramolecular interactions, they have a range of boiling points.  
  TFE as a cosolvent 
A solvent that has proven particularly interesting for the study of helical proteins is 
TFE, shown in Figure 1.7. TFE possesses both a polar hydroxyl group and a triple 
halogenated hydrophobic group, making it an amphipathic molecule. This property 
makes it suitable for stabilising both the hydrophilic surface and the hydrophobic core 
of proteins (3, 138). 
 
Figure 1.7: Structural formula of TFE. 
 
A helix stabilising effect has been observed in polar alcohols previously (139), 
however this has been particularly strong in mixtures of water and TFE. Though the 
cosolvent can also stabilise β-sheets, it has been found to be particularly proficient at 
solubilising and stabilising α-helices (3–5, 140). In fact, it has been observed that the 
degree of helicity increases upon addition of TFE to aqueous solution, to the extent 
that regions which are non-helical in the native state may become helical in TFE-water 
mixtures. In proteins that are not almost exclusively helical, this can mean that tertiary 
structure is disturbed (141, 142).  
The destruction of tertiary structure in favour of stabilisation of helices is 




range interactions (3). In line with this, the effects of TFE on proteins are very 
sequence dependent in that it is challenging to devise a specific scale of helical 
propensity for amino acids irrespective of their environment (143).  
It appears that TFE propagates helices in a cooperative process rather than 
initiating helix formation, with longer helices particularly likely to be extended (139, 
144, 145). TFE therefore does not form a site of helix nucleation, but merely 
exacerbates the intrinsic helical propensity of a protein, more than aqueous solvents. 
In 15% TFE, helical propensity of amino acids is still comparable to aqueous solvents, 
whereas in 40% TFE they are increased for all amino acids (143). This is especially 
prevalent in polar amino acids; glycine and proline, on the other hand, still act as “helix 
breakers” (3). 30% TFE concentration in water by volume appears to be an important 
threshold for protein stability for many proteins, which appear to have reached their 
maximal helicity at this cosolvent concentration and plateau as TFE concentration is 
raised beyond this point (4). In some proteins, the stability of helices even decrease 
upon further addition of TFE (146), although there have been cases where helicity 
continues to increase (147). 
TFE also appears to have a strong effect on protein thermostability. In a study of 
the first 19 residues of ribonuclease A, the peptide displayed a 36% rise in helicity in 
80% TFE compared to aqueous solution at 20 °C (144). This increased by a further 
8% when the temperature was lowered to 3 °C. In line with this, temperature elevation 
has been demonstrated to cause rapid loss of helicity which – in contrast to the 
propagation of helices upon the addition of TFE – proceeded non-cooperatively with 
fraying at the termini of the helices (3, 139). 
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The mechanism for helix stabilisation by TFE is not yet completely understood and 
different models have been suggested. One idea is that TFE molecules directly bind 
the protein and exchange the solvation shell (139). No specific binding sites have been 
suggested, however, at 30% TFE by volume, the protein surface should be saturated, 
which would provide an explanation for the TFE concentration at which many proteins 
achieve their maximal helicity (4, 139, 148). Experimental data from 1H and 19F NMR 
confirm that TFE molecules associate with the surface of a protein and even penetrate 
the core (149). A disruption of the water structure would cause a reduction of the 
hydrophobic effect. This would beg the question whether protein folding – guided by 
the formation of a hydrophobic core – could take place in this medium or whether only 
the stabilisation of folded proteins is feasible in TFE (4). However, even with 
hydrophobic interactions weakened, clusters of hydrophobic sidechains have been 
observed (150) which are most likely stabilised by stacking of aromatic rings (3, 151). 
Others have proposed a less direct interaction of TFE with the protein, a model in 
which hydrogen bonding is the main driving force for TFE-mediated stabilisation of 
helices (145). This effect would be two-fold: Firstly, solvent hydrogen bonds to the 
random coil formation would be decreased, thereby selectively destabilising this 
conformation (144). Secondly, the displacement of water with a large molecule with 
fewer hydrogen bond donor and acceptor sites would strengthen intrapeptide 
hydrogen bonding between carbonyl and amide groups (4, 5, 148). This is supported 
both experimentally and in molecular dynamics simulations (3).  
Another theory was that this phenomenon was mostly dielectric, however this is 
unlikely as a primary driving force as experimental results show variation of TFE 
concentration has little impact on interactions between charged residues of the 




As no one mechanism would fully account for the diverse effects TFE has on 
proteins, it is likely that elements of different mechanisms occur simultaneously. One 
study did indeed suggest an intertwined mixture of the proposed mechanisms, where 
TFE molecules associate with peptides and displace water, providing a low dielectric 
environment that affects hydrogen bonds without disrupting hydrophobic interactions 
(5).  
The structural stabilisation of proteins can in turn have beneficial effects on their 
function, such as an enhancement of catalytic activity in enzymes. For instance, the 
activity of horseradish peroxidase doubled upon the incubation of the enzyme in 5-
25% TFE (6). At higher cosolvent concentrations, however, the enzyme denatures and 
activity declines; in 40% TFE, horseradish peroxidase is entirely inactive (6). 
Furthermore, increasing TFE concentrations have been shown to lead to an increase 
in the volume of horseradish peroxidase. This supports the theory that TFE-induced 
structural changes are largely related to diminishing hydrophobic interactions, which 
would drive the tight folding of a protein in an aqueous environment (6).  
1.4. Enzyme catalysis 
Enzymes are very impressive biocatalysts, able to speed up reaction rates 
significantly with great specificity and selectivity. Without them, most cellular reactions 
would proceed at rates not conducive to life. In a chemical reaction, the rate constant 
k depends on the transmission coefficient κ, the Boltzmann constant kB, the 
temperature T, Planck’s constant h, the universal gas constant R and the Gibbs energy 
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As Figure 1.8 shows, reaction rate is dependent on the free energy of the 
transition state relative to the ground state. Both a catalysed and an uncatalysed 
reaction will result in the same absolute change in free energy between reactants and 
products, ΔG°. However, in the catalysed reaction, the transition state is stabilised by 
the enzyme more than the ground state, resulting in higher kinetic accessibility and 
the resulting lower Gibbs energy of activation ΔG‡, thereby increasing the reaction 
rate.  
 
Figure 1.8: Free energy profiles of an uncatalysed reaction and a catalysed one. 
In both the uncatalysed reaction (blue) and the catalysed one (red), the total change in free energy (ΔG°) 
between reactants (either substrate S or S and enzyme E) and products (product P or P and E) is equal. 
The catalysed reaction proceeds in several steps involving substrate binding, substrate conversion and 
product release. The transition state TS‡ of the substrate is stabilised by the enzyme, which lowers the 
Gibbs energy of activation (ΔG‡) associated with the catalysed reaction compared to the uncatalysed one.  
 
  Substrate binding 
An enzyme catalysed reaction proceeds in multiple steps (10, 23, 25, 134, 154), 




paramount importance for substrate binding. The high substrate specificity of enzymes 
is a result of binding pockets which are highly adapted to their substrates. This model 
for molecular recognition was originally suggested by Emil Fischer who compared this 
to a lock and key, where extreme specificity is also achieved by shape 
complementarity (134). This view was updated to account for the flexibility of enzymes, 
meaning that the binding site is dynamic and somewhat moulded by the substrate 
during binding, described as induced fit. Furthermore, while topology is important, the 
actual binding process requires intermolecular interactions between enzyme and 
substrate. These include electrostatic interactions between charged functional groups 
of the substrate and oppositely charged amino acid side chains. Of course, charges 
are very pH dependent, highlighting the importance of buffered solutions for enzyme 
function. Hydrogen bonding between substrate and enzyme also play a substantial 
role, as do van der Waals interactions. Lastly, the binding site is often located within a 
hydrophobic cleft of the enzyme and hydrophobic interactions between a substrate 
and an enzyme binding site are important in the aqueous environment. As these 
interactions are strongest at short range, proximity between substrate and enzyme is 
an important factor, highlighting the relevance of concentration to reaction rates.  
While substrate binding is required in advance of enzymatic catalysis, it is 
impeding catalysis if this interaction is too strong, which is perhaps counterintuitive. 
However, if the enzyme-substrate complex is bound very tightly, this lowers the free 
energy, and the reaction is thermodynamically less favourable, lowering the reaction 
rate. The major driving force underlying catalysis is the stabilisation of the substrate’s 
transition state by the enzyme, which is generally bound more tightly than the 
substrate (154). The release of the product or products and simultaneous recycling of 
enzyme is generally such a fast process that the catalytic mechanism between an 
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enzyme and a substrate is often viewed as consisting of only two steps, the binding of 
the substrate and the conversion of the substrate to form the product. For most 
enzymes, the rate limiting step is the conversion of the substrate to form the product. 
A perfect enzyme, however, could catalyse the reaction as quickly as it collides with 
the substrate, which is why this concept is referred as diffusion limited. 
  Enzyme kinetics 
Kinetically, it is important to distinguish between single-substrate and multi-
substrate reactions. For single substrate reactions, most reported enzymes obey the 
Michaelis-Menten model (155), although there are some cases where inhibitors or 
allosteric modulation change the kinetics of the reaction. The Michaelis-Menten model 
assumes two steps in a reaction between a single substrate and an enzyme, the 
binding and the conversion of the substrate (Figure 1.9).  
 
Figure 1.9: The Michaelis-Menten model of enzyme kinetics. 
The catalysis of the conversion of substrate S by enzyme E involves binding resulting in enzyme-substrate 
complex ES, followed by conversion of the substrate to product P and its dissociation. 
 
During the course of the reaction, the concentration of product increases and the 
concentration of substrate, of course, decreases. At the commencement of the 
reaction, no product is present, meaning that the conversion of substrate to product is 
a unidirectional process and the velocity of the reaction is linear at this stage. A 
standard curve of a reaction catalysed by an enzyme following Michaelis-Menten 
kinetics is shown in Figure 1.10. The Michaelis-Menten equation can be used to 




([E]0), the initial substrate concentration [S] as well as the turnover number kcat and the 









where kcat denotes the molecules of substrate each enzyme can convert per unit 
time when the reaction proceeds at its maximum velocity. 
 𝑘𝑐𝑎𝑡 =  
𝑣𝑚𝑎𝑥
[𝐸]0
  1.6 
 
The Michaelis constant KM is the substrate concentration where the reaction rate 
is half of its maximum vmax, as shown in Figure 1.10. KM is inversely correlated with 
binding affinity. 
 
Figure 1.10:  Michaelis-Menten curve showing reaction rate versus substrate concentration. 
The initial slope of the curve equals kcat/KM. 
 There are a variety of multi-substrate mechanisms (Figure 1.11), differing by 
two factors. Firstly, whether the substrates are bound and converted individually or 
whether a so-called ternary complex EAB is formed between the enzyme and both 
substrates. Secondly, the reaction via a ternary complex can either be random, 
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meaning the order of binding the substrates is irrelevant to the reaction, or sequential, 
where the reactions can only proceed if substrates are bound to the enzyme in a 
specific order (156).  
This work will focus on the ping-pong mechanism (Figure 1.11 c), to which 
peroxidases typically adhere (2). In the ping-pong mechanism, two substrates 
sequentially react with an enzyme with the formation of an intermediate. Reaction of 
the enzyme (E) with the first substrate (A) proceeds via an enzyme-substrate complex 
(EA) and leads to the formation of an intermediate (E*) and release of the first product 
(P). A second substrate (B) then binds this intermediate and forms a complex of the 
substrate with the intermediate (E*B). As the second reaction product (P’) is released 
(157), the enzyme is recycled back to its resting state. 




















This equation contains two separate values for KM as the Michaelis constants for 
the two substrates are independent of each other. They can be determined individually 













Figure 1.11: Kinetic models for a reaction between an enzyme and two substrates. 
a – Random order ternary complex mechanism. The enzyme E binds substrate A and B in any order to 
form complex EAB which then releases products P and P’, also in either possible order. b – Sequential 
ternary complex mechanism. E binds A and B in a specific order to form complex EAB which then releases 
the products in sequential order. c – Ping-pong mechanism. E first binds A and converts it to P, forming 
intermediate E* which can then convert B to P’. 
 
1.5. Cytochrome structure and chemistry 
A number of enzymes require coenzymes to carry out their catalytic function and 
bind metal ions or small organic molecules such as flavins as prosthetic groups. With 
biological macromolecules generally incorporating very few chemical elements, the 
introduction of metals – either in ionic form or as part of an organic cofactor – 
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example, plays an important role in some metabolic enzymes in humans and 
manganese in photosystem II is crucial in photosynthesis (159, 160). 
The most prevalent transition metal in living organisms, however, is iron, which 
constitutes approximately 50 ppm of the human body by weight (161). It is commonly 
incorporated into enzymes as part of heme, a prosthetic group found in proteins in all 
three domains of life: Archaea, Bacteria and Eukarya (161, 162). Heme is a complex 
of the tetrapyrrole known as porphyrin coordinating the iron ion via four equatorial 
nitrogen atoms, and proteins binding this prosthetic group are called cytochromes.  
Heme groups can be divided into several types, b- and c-type heme being the 
most common (Figure 1.12). Heme B is non-covalently coordinated to the protein 
whereas heme C covalently binds the protein. In most cases the heme C binding site 
is a CXXCH motif, where the sulfur-containing cysteine residues form thioether bonds 
with the porphyrin’s vinyl groups. Histidine acts as an axial ligand. The thioether bonds 
potentially lend the protein more stability than the non-covalently bonded analogues 
and allow for efficient packing of multiple hemes in a protein (163). From a biosynthetic 
point of view, heme B is the precursor for heme C; in E. coli, the heme attachment is 
catalysed post-translationally by the cytochrome c maturation apparatus (Ccm) (164, 
165). Structural analyses of apo- and holoproteins also suggest that in the majority of 




    
Figure 1.12: Chemical structures of heme B (left) and heme C (right). 
Heme C is covalently bonded to a cysteine residue via thioether bonds. 
 
Heme is a versatile prosthetic group and while a large variety of enzymes contain 
heme, not all cytochromes are catalytically active. The tetrapyrrole’s conjugated 
system of delocalised π-electrons can stabilise different oxidation states of the 
coordinated metal ion, giving rise to a variety of activities.  Oxidation states of +2, +3 
and +4 are commonly accessible to the heme iron, which are referred to as ferrous, 
ferric and ferryl iron, respectively (167). Some heme-binding proteins are involved in 
other natural processes, such as storage, transport and sensing of oxygen, common 
functions of the α-helical family of heme proteins known as globins (164, 168). More 
typically, however, cytochromes are involved in electron transfer chains or function as 
oxidoreductases (161). 
  Cytochromes as Peroxidases 
Whilst there is a vast array of functions for heme proteins, many natural 
cytochromes function as redox catalysts known as oxidoreductases. Among these, 
peroxidases are a very important family, which reduce hydrogen peroxide and 
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  1.8 
In nature, peroxidases are expressed in almost all organisms across all domains 
of life where they have a vast array of functions, for example in the metabolism of 
reactive oxygen species, innate immunity, cell wall synthesis and wound healing (169–
175). Although heme is not essential for peroxidase function, over 80% of known 
natural peroxidases are cytochromes (172, 176). Figure 1.13 shows the classification 
of natural peroxidases according to the RedoxiBase (176). It especially highlights 
where within the peroxidase family horseradish peroxidase falls, one of the first 
peroxidases to be discovered and studied, the structure of which is shown in Figure 
1.14. After over a century of research into this enzyme extracted primarily from the 
plant’s roots, it is a very well characterised enzyme that is produced on a relatively 
large scale for a variety of applications. Commercially available horseradish 
peroxidase is typically a composition of isoenzymes, structurally distinct proteins 





Figure 1.13: An overview of classification of natural peroxidases. 
The situation of horseradish peroxidase (HRP) within the peroxidase family is highlighted in red. 
 
In addition to the vast array of functions peroxidases have in vivo, they have been 
utilised in vitro for a variety of functions. Horseradish peroxidase, for example, has 
been extensively used in applications: as an antigen in immunoassays, in the 
biosynthesis of organic polymers, in cancer treatment, and in electrochemical sensors 
(173, 177). 
 






Figure 1.14: Structure of horseradish peroxidase C1A. 
a - Cartoon representation of horseradish peroxidase (left), with C45 (right) shown for scale (178).         
b - Detailed view of the heme environment in horseradish peroxidase, with heme shown in red, helices 
in blue, β-sheet regions in pink, loops in yellow and the endogenous Calcium ions as green spheres. The 
histidine residue in position 170 which coordinates to the heme iron is shown in light blue. Figure 









1.6. Enzyme Engineering 
Whilst enzymes have demonstrated impressive versatility for uses in 
biotechnology, medicine and chemistry outside of their natural environment, they 
remain highly evolved machines catalysing very specific reactions under very specific 
conditions. This means that the variety of applications is limited by the natural range 
of proteins that have evolved by natural means and any applications must be adapted 
to the proteins abilities and working conditions. Consequently, there has been 
considerable interest in modifying proteins to tailor them for specific applications. Of 
course, the idea of adapting, modifying, imitating and recreating natural processes and 
products is not restricted to proteins. The expanding field of synthetic biology has also 
successfully produced artificial protocells that allow for cell free gene expression 
systems, DNA origami and artificial viruses for more efficacious vaccines (179–183). 
As for producing man-made proteins, the two routes being explored are the 
modification of natural proteins and the creation of entirely novel proteins (which can 
then, of course, be subject to further modification). Proteins are very suitable for both 
of these as they are built from individual blocks – the twenty naturally occurring amino 
acids – that can individually be replaced to alter structural and functional 
characteristics (184).  
  Directed Evolution 
Directed evolution has been used extensively to modify proteins; a small scale, 
laboratory method imitating Darwinian evolution where repeated mutations along with 
selective preservation and enhancement of the most advantageous traits for survival 
lead to amplification of desirable attributes over time. Partial randomisation of genes 
encoding a protein leads to a multitude of variants which can be screened for particular 
characteristics – such as specific ligand binding or enhanced enzyme kinetics – which 
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are then selectively amplified through PCR (185–187). However, the identification of 
molecules showing desired traits in the large number of proteins produced remains a 
challenge in specific protein modification through directed evolution. Mathematical 
modelling and computational biochemistry have been increasingly used to tackle this 
problem (184, 188–190). 
Overall, directed evolution, though not specific to enzymes, has played an 
important role in contemporary enzymology. Its impressive accomplishments include 
enhanced enzyme specificity, increased catalytic efficiency and stereospecificity. 
Horseradish peroxidase has been subject to directed evolution to achieve higher 
thermostability and better longevity for the multitude of in vitro applications for which 
this well characterised cytochrome has been employed (175).  The surface and the 
loop regions proved especially good targets for mutations, which is unusual in heme 
enzymes, where mutations are commonly focussed on the active site (175, 185). 
A further achievement of directed evolution receiving a lot of attention in recent 
years is the attainment of enzyme promiscuity, so that they can react with unnatural 
substrates to perform stereospecific chemistry not possible in the natural environment 
in vitro (191, 192). Frances Arnold, Nobel laureate in Chemistry in 2018 for her work 
on directed evolution of enzymes, has shown a 9000-fold increase in catalytic 
efficiency for propane oxidation by a modified cytochrome P450 (193, 194).    
  De novo enzyme design 
A significant limitation of directed evolution, however, is the very small fraction of 
the total possible sequence space that can be covered. There are 20n possible amino 
acid sequences for a protein with n amino acid residues, typically in the hundreds. 




approximately 1012 distinct proteins being produced by living organisms (1, 184). 
Directed evolution widens the subset of sequence space that is open to investigation 
slightly by producing variants related to natural proteins. However, this still leaves a 
vast amount of potential sequence space that remains unexplored by both natural and 
directed evolution; the possibility of venturing into these novel territories has been the 
motivation behind de novo protein design, as shown in Figure 1.15.  
 
Figure 1.15: Schematic diagram of the protein sequence space.  
Nature has only explored a tiny fraction of the possible protein sequences (blue), meaning native proteins 
(orange) only take up a small part of the sequence space. Directed evolution allows us to explore the 
space surrounding the “islands” of natural proteins (white), but cannot venture into the vastness of 
unexplored sequence space; de novo protein design, however, is free to explore any part of the protein 
sequence space that may be impossible to investigate otherwise. Figure adapted from (1). 
 
De novo, a phrase meaning ‘from the beginning’ (or literally translated from Latin 
as ‘of new’) is an approach to protein engineering that seeks to design proteins from 
scratch by creating novel sequences from natural amino acids. Of course, this bottom 
up method requires a much deeper understanding of the biochemistry of protein 
stability, folding and functionality. A key advantage of directed evolution is that a 
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protein with a single point mutation is likely to take a similar three-dimensional shape 
as the native protein on which the design was based, resulting in predictability of 
protein structure and stability. A completely novel polypeptide, on the other hand, may 
not successfully fold into a stable or functional biomolecule at all. However, with a 
good understanding of protein biochemistry, de novo protein design could open up 
endless possibilities to tackle challenges within and outside the fields of biology, 
especially with the growing number of applications of proteins in vitro. 
Much de novo protein design is based on computational methods where 
programmes such as Rosetta can be used to calculate the energy of an amino acid 
sequence and predict the three-dimensional protein structure from this (1).  Using 
these in silico methods, both globular and membrane proteins have been successfully 
designed (195–197). Other groups have used the principles of protein engineering to 
produce multichain polypeptides that assemble into particles or vesicles (198–200).   
  The maquette approach 
The first artificial four-helix bundle proteins were designed by DeGrado lab in the 
1980s by mimicking the hydrophobic and polar amino acid patterning of natural four-
helix bundles (17, 201–203).  Building on this, the maquette approach developed by 
Dutton has been successful in designing a number of four-helix bundle proteins (18, 
19, 204). This non-computational bottom-up method starts with a simple, generic 
protein sequence with minimal complexity encoding a bundle of helices with repeated 
amino acid sequences in a heptad of hydrophobic (H) and polar (P) amino acids in an 
HPPHHPP pattern. Subsequently, cofactors can be added to this protein scaffold to 
allow functionality, resulting in robust, operative proteins. This simplicity allows these 




undergone millions of years of evolution, with the possibility of changing individual 
amino acids (205). These synthetic maquettes can not only incorporate a wide range 
of natural cofactors, such as metal ions or flavins but also self-assemble in vivo (19, 
20). A diverse range of function can be imparted on the protein by choice of cofactor; 
maquettes have been produced with functions including light-harvesting (206), energy 
transfer (207), magnetosensing (208) and transmembrane electron transfer  (209). 
Many maquettes are cytochromes, thus binding heme as a cofactor, an exceptionally 
diverse and common natural cofactor which is also bound by some naturally occurring 
four-helix bundle proteins (210, 211).    
1.7. C45 – a de novo designed four-helix bundle 
In the Anderson group, a variety of four-helix bundles have been designed using the 
maquette approach and assembled in vivo in E. coli (2, 20, 21, 212). The work herein 
will focus on C45, a cytochrome with peroxidase functionality developed in multiple 
rounds of mutagenesis. The initial maquette design from which C45 was developed 
includes four helices as well as flexible loops comprising of glycine and serine. The 
cellular cytochrome c maturation apparatus incorporates the heme cofactor by 
covalently linking it to the cystine side chains of the CXXCH binding motif via two 
thioether bonds. This heme C binding motif can be located on any of the four helices, 
producing different types of maquettes named C1, C2, C3 or C4, depending on the α-
helix where the heme C binding motif is located. These four proteins were analysed 
biophysically using circular dichroism spectroscopy. With the highest helicity 
proportion and the second highest melting temperature of 51 °C, C4 seemed the most 
suitable of these four maquettes to further modify to incorporate peroxidase activity (2, 
21).  
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C4 is a di-heme protein: firstly, the aforementioned CXXCH motif (in this case 
CIACH) is located on the fourth helix, which covalently binds c-type heme. In addition 
to the two thioether bonds to the tetrapyrrole, the heme is also ligated via a bis-histidine 
pair on helices two and four. A further bis-histidine pair on the other two helices serves 
as another heme binding site. This four-helix bundle was modified further (Figure 
1.16) to produce a robust heme C binding redox catalyst. The first step of this process 
was the removal of the bis-histidine pair that form the non-covalent heme binding site 
on the first and third helix to construct a maquette called C46. The two histidine 
residues were replaced with phenylalanine to improve the packing of the protein’s 
hydrophobic core and rigidify the protein. This enhanced the stability, as seen by the 
raised melting temperature (from 51 °C to 84 °C). The protein retained the covalent 
binding motif CXXCH on the fourth helix and the two histidine residues ligating the 
covalently bound heme. C46, however, did not show significant peroxidase activity, 
but instead bleached under addition of H2O2 and the common peroxidase substrate 
ABTS, which indicates heme degradation (2). Imitating natural peroxidases, which 
typically incorporate a mono-histidine ligated heme (213), the distal heme-ligating 
histidine residue on helix two was also substituted with phenylalanine. This resulted in 
C45, a mono-heme ligating four-helix bundle maquette protein, which retains the great 
thermostability of C46 (TM of C45 is 86 °C). Figure 1.17 shows a cartoon 






Figure 1.16: The design of heme-binding four helix bundle maquette protein C45.  
The initial maquette protein is C4, a four helix bundle with a single CIACH motif on the fourth helix 
covalently binding heme C which is also ligated by a bis-histidine pair on helices 2 and 4. A bis-histidine 
pair on the other two helices forms another, non-covalent tetrapyrrole binding site. In the next step, the 
two histidine residues in these locations are replaced with phenylalanine and the non-covalent heme 
binding site thereby removed. This protein is called C46. This is further modified in a final step by removing 
the distal iron coordinating histidine residue and replacing it with phenylalanine. The resulting mono-
histidine ligating maquette is C45. Adapted from (2). 
 
In steady-state kinetic assays, C45 demonstrated the desired peroxidase activity. In 
contrast to C46, C45 reacted with H2O2 and ABTS (Figure 4.4) obeying ping-pong 
steady-state kinetics, like many of the natural peroxidases (2). With a kcat/KM (ABTS) of 
3.2 × 106 M-1 s-1 C45 showed high catalytic efficiency comparable to some other heme-
containing de novo peroxidases (214, 215). This catalytic efficiency was even 
comparable to that of natural peroxidases, such as HRP, for which a kcat/KM (ABTS) value 
of 5.1 × 106 M-1 s-1 has been measured (216). C45 showed great substrate 
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promiscuity, too, as well as catalytic promiscuity, being capable of oxidative 
dehalogenation of halogenated phenols with 5 times greater catalytic efficiency than 
a natural dehaloperoxidase (217). Furthermore, ferrous C45 could take part in 
interprotein electron transfer (218) with cytochrome c due to the complementary 
electrostatic surfaces. This is in agreement with other work with heme maquettes and 
natural cytochrome c peroxidases (213, 219). More recently, the enzyme was also 




Figure 1.17: Cartoon representation C45 with an inset showing the environment of the heme cofactor in 
detail .  
α-helices are shown in blue, red represents the loops between the helices, phenylalanine residues that 
were mutated from histidine in C4 and C46 are shown in pink and the histidine residue in the heme 
binding motif in the fourth alpha helix is shown in green, coordinating a single heme, shown in grey.  
Further, tryptophan residues are shown in orange as preliminary data from electron paramagnetic 
resonance spectroscopy confirmed the presence of a tryptophan radical during the enzyme’s catalytic 
cycle. This is most likely W43, which is located closest to the heme cofactor and can be seen in the inset.  




C45 also exhibited remarkable resilience not only to high temperatures, as 
demonstrated by the high TM and also the reversibility of thermal denaturation, but 
also to the presence of low concentrations of some alcohols. In temperatures of up to 
70 °C, catalytic activity of the enzyme further increased. Limited work has been done 
regarding the stability of the enzyme in organic cosolvents. In concentrations up to 
30% ethanol, ABTS oxidation proceeded with similar catalytic activity as in pure buffer 
(2). In higher ethanol concentration, activity declines significantly. In methanol 
concentrations of up to 50%, catalytic activity of dehalogenation of 2, 4, 6-
trichlorophenol in the presence of H2O2 only decreases by about 25%. This thesis 
seeks to further explore this impressive resilience to such hostile environments
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1.8. Aims of this work 
Whilst a fair amount of work has been carried out investigating the behaviour of 
enzymes in organic solvents, this has mostly focused on simple, hydrolytic enzymes 
(13).  
One of the primary advantages of maquettes is the ability to work with an 
evolutionary naïve protein that does not exhibit the complexity of its natural analogues. 
This makes C45 a suitable candidate to study the effect of organic cosolvents on the 
structure and function of a heme-binding oxidoreductase. To that end, chapters 3 and 
4 describe the effects of acetonitrile, methanol, ethanol, isopropanol and TFE on the 
enzyme’s structural integrity and catalytic activity, respectively. CD and UV-vis 
spectroscopy experiments are presented that probe the structure of the enzyme in 
cosolvent, whereas steady-state kinetics of the oxidation of ABTS by C45 and 
hydrogen peroxide are presented to elucidate changes in the enzyme’s catalytic 
behaviour. 
In these studies, a remarkable effect of TFE could be shown, which is highly 
beneficial for activity and increased the catalytic turnover number by a factor of 7. In 
order to elucidate this effect, further structural analyses are presented using SAXS, 
analytical size exclusion chromatography and NMR. These indicate that the effect of 
TFE is twofold. Firstly, it structurally stabilises C45, which reproduces its effects on 
other helical proteins. Secondly, the stabilising effect also influences the reactive 
catalytic intermediate compound I, thereby preventing the degradation of the protein 
and enhancing total turnover number. 
This work could provide a model for other helical enzymes, which may exhibit 




2. Materials and Methods 
 
C45, the protein used in this work, was expressed in  E. coli containing the plasmid 
vectors for the protein and the E. coli cytochrome c maturation apparatus, conferring 
resistance to carbenicillin and chloramphenicol (2, 221). The protein was then purified 
using nickel affinity chromatography and size exclusion chromatography, which is a 
method of separating mixed protein samples based on the size of individual species 
(Figure 2.1). Smaller species diffuse more into resin and pass through the porous 
network, thus having a longer path length through the column. Elution times are 
therefore inversely correlated with the size of a protein. Originally intended as a means 
of purifying proteins, this technique can also be used analytically to separate a sample 
by size of species present (25, 221). To confirm the presence and purity of C45, SDS-
PAGE was employed, a commonly used method of analysing protein size, 
concentration and purity of samples of denatured and SDS-bound proteins based on 
distance travelled within a charged hydrogel (222).  
The protein was further characterised using UV-visible spectroscopy. This 
technique can supply information about protein concentration, using the Beer-Lambert 
law: 
 
𝐴 =  𝑐 𝑙 
2.1 
where A is absorbance, ε is the extinction coefficient that is specific for a species 
measured at a specific wavelength, c the concentration of that species and l the path 
length. 




Figure 2.1: Size-based separation of three species by size exclusion chromatography. 
The larger species (red) interacts less with the porous resin and elutes earlier, while smaller species (blue 
and green) pass through the porous network within the beads, thereby taking a less direct path and 
eluting later, as a larger fluid volume has passed through the column. There is therefore an inverse 
correlation between the species size and supplied fluid volume with which it elutes. The upper limit for 
elution volume is set by the column volume. Figure adapted from (223). 
 
Furthermore, UV-visible spectroscopy is also very pertinent in providing insights 
into prosthetic groups and their chemical environments, such as the oxidation state of 
metal ions or metallic cofactors (224). In proteins, absorptions between 180 and 230 
nm are associated with π-π* and n-π* transitions in the peptide bonds. The aromatic 
side chains of tryptophan, tyrosine and phenylalanine residues lead to absorption in 
the range of 230-300 nm similar to disulfide bonds that absorb at approximately 260 
nm (225). These absorbances can be employed for determination of protein 
concentration. Additionally, a cofactor may also absorb UV-visible light. Heme, for 
instance, has a strong band of absorption in the region of 400 - 410 nm caused by π-
π* transitions known as the Soret band (226). The exact location of this band is 
dependent on the ligation, chemical environment as well as the oxidation state of the 
heme iron. In addition to the Soret band, Q-bands in the region of 520 – 550 nm can 
give more accurate information about the heme environment. UV-visible spectroscopy 
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can also be employed to acquire a pyridine hemochrome, as described in section 
2.2.6. The concentration and identity can be worked out from the relative intensities 
and positions of the Q-bands located between 500 nm and 600 nm; Berry and 
Trumpower give extinction coefficients for both reduced and oxidised species of all 
three types of heme (227, 228). 
A further technique employed for the characterisation of C45 is circular dichroism 
spectroscopy (CD). CD can be used to analyse secondary structural elements of a 
protein, such as α-helices or β-sheets. The technique is based on a protein sample 
absorbing left- and right-handed circularly polarised light differently owing to the 
chirality of amino acids. This results in a beam of elliptically polarised light where the 
degree of ellipticity can be measured. Different motifs of secondary structure exhibit 
distinct, characteristic CD spectra due to different arrangements of the chiral amino 
acids (229, 230). A benefit of CD is the ability to perform thermostability studies by 
continuously monitoring the sample at a specific wavelength or collecting full spectra 
at regular intervals as the sample is heated (231). An important limitation of the 
technique, however, is that CD can only be employed to investigate secondary 
structure and provide very little information regarding tertiary structure. 
Nuclear magnetic resonance spectroscopy (NMR) provides some information on 
the chemical environment of specific nuclei, most importantly 1H and 2H (or D), 13C as 
well as 15N (232). It is based on certain nuclei possessing magnetic moment and their 
alignment with an external magnetic field. This alignment can be perturbed with a 
pulse of electromagnetic energy. The resonant frequency is dependent on the 
magnetic field observed at the nucleus, which is dependent not only on the strength 
of the external magnetic field, but also on the nature of the nucleus and its chemical 
environment, as electron density has a shielding effect (233). 
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Two-dimensional (2D) NMR is a method to gain more accurate information with 
better resolution about large molecules, such as proteins. In heteronuclear NMR 
focussing on 1H and 15N nuclei, magnetisation is transferred between those two nuclei. 
A multitude of different 2D NMR techniques involving these nuclei exists, which differ 
in the type of pulse sequence used to excite nuclei. In this work SOFAST-HMQC and 
TROSY-HSQC were used. The former had previously been employed for the 
characterisation of C45 while the latter was chosen due to its sensitivity for 
macromolecules with a molecular mass of up to 80 kDa (234, 235). 
Small angle X-ray scattering (SAXS) can provide information on the size and 
shape of a protein. This method does not require crystallisation or freezing of the 
protein, but can be carried out in solution which greatly facilitates analysis. During this 
rapid technique, a monochromatic X-ray beam passes through a sample (Figure 2.2).  
 
 
Figure 2.2: Schematic representation of a SAXS experiment. 
A monochromatic x-ray beam passes through a solution of protein, which diffracts the beam. The 
scattered x-rays are detected and scattering angles measured. Figure adapted from (236). 
 
Proteins in the sample solution scatter the beam before it reaches a two-
dimensional detector. The angles by which the incident beam differs from the scattered 
beam (2θ) can be used to calculate the scattering vector q (237): 










To investigate the enzyme’s catalytic activity, steady-state kinetic 
measurements were performed, referring to a stable concentration of the enzyme-
substrate complex. This can be performed on a UV-visible spectrophotometer or a 
plate reader, which yields less precise data, but is a good method for the acquisition 
of a large number of repeat measurements. In order to investigate the initial stages of 
a reaction accurately, stopped flow spectrometry is most appropriate. During stopped 
flow spectrometry (Figure 2.3), an air pressure driven mechanism rapidly injects fixed 
volumes of fluid from two syringes into a mixing cell (in this case C45 and the 
substrates). Once this mixing cell is filled, flow is immediately halted, and the 
measurement triggered. An incident light beam passes through the chamber and the 
change in absorbance or fluorescence can be measured. A connected photomultiplier 
or photodiode array helps detect the absorbance changes and convert this 
measurement into a spectrum of light absorbance over time. Photodiode array 
detectors and photomultipliers differ in measuring multiple wavelengths or a single 
selected one, respectively (238). The advantage of stopped-flow spectrophotometry is 
the speed at which mixing and measurement can proceed, which makes it possible to 
accurately observe the kinetics of the first seconds of a reaction, which is not possible 





Figure 2.3: Schematic representation of a stopped-flow spectrometer. 
A pressure driven piston initiates the rapid release of equal fluid volumes from syringes 1 (containing C45 
solution) and 2 (containing substrate solution) into the mixing cell. A stop syringe also connected to the 
mixing cell acts as a backstop when the mixing cell is filled. A light beam passing through the sample is 
detected using a photodiode array detector. These results are recorded as a graph showing absorbance 
over time for all wavelengths measured. Figure reproduced and adapted from (238) 
 
2.1. Materials 
Chemicals used within this project were purchased from Sigma-Aldrich, 
ThermoFisher Scientific, Alfa Aesar and Apollo Scientific. Additionally, sterile and 
deionised water was used, generated using a Milli-Q Integral Water Purification 
System by Merck Millipore. The pSHT vector for C45 protein was produced by Dr 
Daniel Watkins (University of Bristol, School of Biochemistry).   
2.2. Methods 
Unless specifically mentioned otherwise, percentage mixtures of solutions always 
refer to volume by volume. 
 
2. Materials and Methods 
55 
 
  Protein Expression 
C45 (Figure 2.4) was expressed in T7 express E. coli BL21 (DE3) co-transformed 
with vector pEC86 encoding for the c-type cytochrome maturation system Ccm. Cells 
from glycerol stock were grown in sterile LB broth (10 g tryptone, 5 g yeast extract, 10 
g NaCl per litre purified water) treated with carbenicillin (50 μg/ml) and 
chloramphenicol (34 μg/ml) and incubated at 37 ºC shaking at 200 rounds per minute. 
Protein expression was induced with the addition of isopropyl β-D-1-
thiogalactopyranoside (IPTG, 1mM) and the cultures were incubated for a further 4-5 
hours. A cell pellet was collected by centrifugation (25 minutes, 4,500 × g, 8 ºC) and 
resuspended in lysis buffer (300 mM NaCl, 50 mM sodium phosphate, 20 mM 
imidazole, pH 8.0). 
The cell pellet was lysed by means of sonication (4 × 20 seconds, 23 kHz) and 
centrifugation (30 minutes, 40,000 × g, 4 ºC). The filtered lysate was purified using 
nickel affinity column chromatography (GE Healthcare Life Sciences HisTrap HP 5ml, 
equilibrated in lysis buffer). A gradual increase in imidazole concentration was used to 





Figure 2.4: Sequence of C45. 
a – Diagram of the different elements of the protein; the signal sequence at the N-terminus is cleaved 
when the protein is transported into the periplasm by the Sec translocon and serves as a recognition site. 
The His-Tag consisting of 6 histidines is used for purification using nickel affinity chromatography and may 
subsequently be cleaved from the protein using tobacco etch virus (TEV) protease. The plasmid was 
named pSHT due to the different elements of the protein (signal sequence, His-Tag, TEV protease 
recognition site). b - The amino acid sequence of C45. The protein can be cleaved between Q and G at 
the TEV cleavage site (yellow) using tobacco etch virus (TEV) protease to remove the hexahistidine tag 
(green). Alternating polar and non-polar amino acids results in self-assembling α-helices, here shown in 
red. These four helices are connected via three loops (purple). The CXXCH heme binding motif located on 
the fourth helix is shown in orange. Adaptation from (20).  
 
  Cleavage of the His-Tag and further purification 
Cleavage of the 6-histidine tag was achieved in TEV cleavage buffer (20 mM Tris, 
0.5 mM EDTA, pH 8.0) under anaerobic conditions with the addition of the reducing 
agent Tris(2-carboxyethyl)phosphine (TCEP, 1mM) and tobacco etch virus (TEV) 
protease (100 μg per 1 L expression culture). After 6 hours, the cleaved C45 was 
purified using nickel affinity chromatography and size exclusion chromatography and 
analysed using SDS PAGE.  
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 Size exclusion chromatography 
Size exclusion chromatography was conducted at room temperature on ÄKTA 
systems by GE Healthcare (specifically the ÄKTA explorer and ÄKTA pure). A filtered 
buffer of pH 8.6 containing 20 mM CHES and 100 mM KCl was used. Different 
columns were utilised for analytical size exclusion chromatography (SEC) and SEC 
with the purpose of protein purification; the former was conducted on a Superdex 75 
Increase 10/300 GL, the latter on a Superdex 75 pg HiLoad 16/600 column. Both 
column types were purchased from GE Healthcare; flow rates and pressure limits were 
set in accordance with manufacturer’s instructions.  
  Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) 
SDS-Page experiments were conducted using NuPage Tris-glycine precast gels 
with a 4-20% polyacrylamide content from Life Technologies and NuPage MES SDS 
Running Buffer (50 mM MES, 50 mM Tris Base, 0.1% SDS, 1 mM EDTA, pH 7.3). 10 
µl protein samples were mixed with 10 µl sample application buffer (50 mM Tris, 5% 
SDS, 30 % glycerol, 50 mM EDTA, 5% β-mercaptoethanol, 74.6 µM bromophenol 
blue, pH 7.0) before being denatured at 95 °C for 10 minutes and applied to the gels 
alongside PageRuler Prestained Protein Ladder (from Life Technologies) and run at 
250 V for 30 minutes. Gels were stained using a solution of 25% ethanol, 10% acetic 
acid and 3 mM Coomassie Brilliant Blue R-250 before destaining in 20% ethanol, 5% 
acetic acid. 
 UV-visible spectroscopy 
UV-visible spectrometry was conducted on a Cary 60 UV-visible 




mm were used. Spectra of buffer solutions (with cosolvent, if appropriate) were 
recorded and subtracted. Unless otherwise specified, all measurements were taken at 
room temperature. 
  Pyridine Hemochrome 
A 120 µl sample of C45 with a concentration of 10-12 µM was mixed with 15 µl of 
5M NaOH and 15 µl of pyridine (for protein denaturation and coordination of the heme, 
respectively). A UV-visible absorption spectrum was obtained and C45 subsequently 
reduced using sodium dithionite before another spectrum was obtained. This is an 
adaptation of a method described by Berry and Trumpower (227, 228). 
  Circular Dichroism spectroscopy 
Samples for CD were prepared by mixing 4 nanomoles of C45 in buffer (so that 
the final concentration of C45 in 0.5 ml of solution would be 8 μM). This was then 
mixed with the desired volume of cosolvent to make up 0.5 μl, mixed thoroughly and 
transferred to a quartz cuvette with 1 mm path length. Protein concentration was 
determined using the absorbance at the heme Soret peak, where C45 has a known 
absorption coefficient of 147,300 M−1 cm−1 (2). It is worth noting that this accounts only 
for holoprotein and not apoprotein. Therefore, any apoprotein present would lead to 
higher protein concentrations than calculated. 
Circular dichroism (CD) experiments were carried out on a Jasco J-810 
spectrophotometer under nitrogen atmosphere. Buffer solution (with cosolvent 
depending on the experiment) was recorded as a baseline and subtracted from the 
results. Scans were taken at a rate of 100 nm per minute and a temperature of 25 ºC.  
Thermal denaturation studies were conducted with a ramp of 1 °C/minute (except 
where specified otherwise), starting at 8 °C. Continuous measurements were taken at 
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222 nm, with additional full spectra taken at temperature intervals of 10-15 °C. When 
the top temperature was reached, a cooling cycle was immediately initiated, using the 
same conditions. 
To normalise data for pathlength, concentration and number of peptide bonds in 
the protein (n), data were converted to mean residue molar ellipticity θ using the 
following equation (239): 
 𝛩(deg 𝑐𝑚2 𝑑 𝑚𝑜𝑙−1) = 
𝐸𝑙𝑙𝑖𝑝𝑡𝑖𝑐𝑖𝑡𝑦 (𝑚𝑑𝑒𝑔)𝑥 106
𝑃𝑎𝑡ℎ𝑙𝑒𝑛𝑔𝑡ℎ (𝑚𝑚)𝑥 [𝑃𝑟𝑜𝑡𝑒𝑖𝑛](µ𝑀)𝑥 𝑛
 2.3 
 
  Nuclear Magnetic Resonance  
For heteronuclear 2D-NMR, 15N-labelled protein was expressed in minimal media 
supplemented with 1 g of 15NH4Cl to 1 litre LB Broth. The addition was performed at 
the point of IPTG induction. Labelled protein was purified using the previously 
described expression protocol. NMR samples contained 250 μM 15N-C45 in 100% 
redox buffer (20 mM CHES, 100 mM KCl, pH 8.6) containing 10% D2O. A second 
sample was prepared with 80% deuterated TFE and 20% redox buffer with 10% D2O.  
All experiments were performed on a Bruker Avance II 700 MHz instrument 
equipped with a 1.7 mm TXI Z-gradient probe at 298 K. 
  Small Angle X-ray Scattering  
1 mM C45 in redox buffer (20 mM CHES, 100 mM KCl, pH 8.6) and 0.7 mM C45 
in 20% redox buffer and 80% TFE were used. Small angle x-ray scattering (SAXS) 
was conducted at 25 °C on a beam line directly connected to a Superdex 75 Increase 
10/300 GL analytical size exclusion chromatography column. The experiments were 




line which delivers approximately 3 × 1012 photons per second to the sample, over a 
cross-sectional area of 1.6 mm2. Data were fitted using ScÅtter and ATSAS software 
(240, 241). 
  Steady-state kinetic analysis 
Whole spectra were taken on a Cary 60 UV-visible Spectrophotometer by Agilent 
Technologies with the Kinetics software by Agilent. Substrates and enzyme were 
added to a quartz cuvette immediately before the experiment and mixed by rapid 
pipetting. 
The peroxidase activity at low substrate concentrations was observed on a 
Synergy neo2 multi-mode reader by BioTek Instruments using StarLab 96-well 
microplates with flat-bottomed, round wells. All reactants were preincubated in the 
experimental concentration of cosolvent. ABTS was injected into the wells and 
immediately prior to the measurement, H2O2 and enzyme were added, and the plate 
stirred. All additions of reactants were done using the instrument’s built-in injector 
system to a total volume of 200 μl. 
  Kinetic analysis with varying substrate concentrations 
For rapid kinetic measurements with higher and varying substrate concentrations, 
an Applied Photophysics SX20 Stopped-Flow spectrometer was used. The instrument 
employed here was connected to a photodiode array detector. Prior to kinetic 
measurements, a baseline measurement of buffer with cosolvent was taken. All 
reactants were preincubated in cosolvent. Immediately prior to measurements, 
hydrogen peroxide and ABTS were mixed, and the two syringes filled with this mixture 
and with enzyme solution, respectively. Syringes and chamber were thoroughly 
flushed between measurements. 
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  Data analysis 
Data analysis and visualisation was performed using Microsoft Office programmes 
as well as Origin Lab Graphing Software, GraphPad Prism, ChemDraw Professional, 
























3. Structural characterisation of 
C45 in organic cosolvents 
 
In this chapter, the structure, especially secondary structure, and thermostability 
of C45 are analysed. The enzyme is monitored during the purification process and 
once fully purified, both in buffer and in a variety of aqueous-organic mixtures using 
UV-visible and CD spectroscopy. The protein’s structural resilience to high 
temperatures is probed using CD temperature wavelength scans in buffer as well as 
aqueous-organic media.  
3.1. Introduction 
C45 consists of four α-helices connected by short loops. The fourth helix 
covalently binds a single c-type heme (19–21). Previous characterisation of C45 has 
largely focussed on the enzyme in conditions imitating those in which proteins have 
evolved in the natural environment. Typically this involves buffered solutions at neutral 
pH and room temperature (2, 21). Only limited data are available for the behaviour of 
C45 in hostile conditions such as organic solvents (2). These data indicate that the 
enzyme is highly thermostable and very catalytically efficient in temperatures up to 70 
°C (and possibly higher). Furthermore, previous work suggests that peroxidase activity 
may increase slightly in low ethanol concentrations of up to 30%. Higher ethanol 
concentrations, however, lead to a strong decline in reaction rate most likely due to 




concentrations, but the activity decline at concentrations above 30% is less 
pronounced than in ethanol. 
Work with enzymes in organic solvents is not merely motivated by the curiosity-
driven pursuit of a better understanding of enzymes, their chemistry and limitations. 
While this may have initiated research in this field, the intriguing results of improved 
thermostability and selectivity generated industrial interest in this field (13, 118, 243, 
244). Furthermore, the ability to work in non-aqueous solvents facilitates the use of 
organic compounds insoluble in water for industrial biocatalysis (7).  
In some instances, pure hydrophobic solvents have proved more beneficial to 
enzymatic activity than mixtures of organic solvents and aqueous media (13). This 
may be partly attributed to a pH memory effect – a term coined to describe the 
phenomenon of enzymes retaining their last ionisation state from aqueous media 
when dehydrated and dissolved in organic solvents (13). However, the use of organic 
solvents as media for proteins poses some challenges: Not only are dehydrated 
proteins often not particularly soluble in organic solvents, but the dehydration process, 
typically achieved by lyophilisation, can lead to protein denaturation as discussed in 
section 1.3.1 (13). During lyophilisation, any water molecules tightly bound by the 
enzyme remain associated with it, potentially a contributing factor to the perhaps 
surprisingly good performances of some enzymes in neat, organic solvents.  
In contrast to water immiscible organic solvents, miscible cosolvents may have a 
much stronger effect on an enzyme’s hydration shell. Hydration is very important both 
structurally and functionally, and in homogeneous aqueous-organic mixtures, 
molecules from the hydration shell are more likely exchanged with the solution (13, 
104). This can lead to the disruption of hydrogen bonding networks and unfolding of 
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the protein in micelles, where the hydrophobic core of the protein is stabilised by the 
organic phase (245).     
This work focusses on the characterisation of C45 in mixtures of aqueous buffering 
solutions and hydrophilic cosolvents. Their effect on the enzyme’s structure and 
function will be probed by gradually increasing cosolvent concentration. The solvents 
used in this work are described in Table 3.1.  
Methanol, ethanol and isopropanol are alcohols with increasing lengths of 
hydrocarbon chain, meaning an increasing proportion of the molecule exhibits 
hydrophobic properties. Acetonitrile has similar chemical properties to isopropanol in 
terms of polarity as measured by Lewis acidity (246), however it lacks a hydrogen 
bond donor. TFE may yield especially interesting results as it has been shown to 
stabilise helical proteins; in fact, TFE has been shown to alter the tertiary structure of 
some proteins to allow for more helicity than the native state possesses (4). The 
dielectric constant, which is a measure of polarity based on physical properties (246), 
has been demonstrated to be correlated to protein mobility (130). It is highest in water, 
meaning all cosolvents have significantly lower permittivity. These cosolvents are, 
however, not mixed with water, but with buffered solution containing salts raising 
solution permittivity. The negative impact of raising cosolvent concentration on the 
dielectric constant is therefore twofold: firstly, the cosolvent has a lower dielectric 
constant than water, secondly salt concentration is lower in higher cosolvent 
concentration. The table also shows ET(30) values, which is a common scale of solvent 
polarity from chemical properties, defined as the molar transition energy of betaine, a 
solvatochromic dye  (246–248). Polarity is likely to affect the folding process which is 
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Water  H2O 
 
100 °C 80 63 14 
Data obtained from (250–259). 
 
The work presented in this chapter screens C45 for structural changes and 
thermostability in buffer and in a variety of solvents. First, C45 was analysed during 
the expression and purification process using UV-visible spectroscopy and SDS-
PAGE.  
CD spectroscopy can provide insights into the secondary structure of proteins in 
solution. During CD, a beam of circularly polarised light (Figure 3.1 a) is passed 
through a sample held in a quartz cuvette. Chiral molecules, such as amino acids, 
absorb left- and right-handed circularly polarised light differently. This effect does not 
only arise in a chiral centre, but also in species in an asymmetric environment, such 
as amino acid side chains (260–262). 




Figure 3.1:  Circularly polarised light and its interaction with optically active matter. 
a - Diagram visualising right-handed circular polarised light (RCPL). Figure taken from (263). b - The 
ellipticity angle θ, showing the rotation of the circular polarised light by an optically active sample in 
circular dichroism spectroscopy. 
 
This leads to elliptically polarised light which has been rotated and distorted by the 
ellipticity angle θ (Figure 3.1 b). For comparability of CD results, the ellipticity is 
converted to molar residue ellipticity (θ) by normalising for sample concentration, 
protein sizes and path lengths of light using the following formula (264) where n refers 
to the number of peptide bonds: 
 𝜃 (𝑑𝑒𝑔 𝑐𝑚2  𝑑𝑚𝑜𝑙−1) =  
𝐸𝑙𝑙𝑖𝑝𝑡𝑖𝑐𝑖𝑡𝑦 (𝑚𝑑𝑒𝑔)
𝑃𝑎𝑡ℎ 𝑙𝑒𝑛𝑔𝑡ℎ (𝑚𝑚)∗[𝑃𝑟𝑜𝑡𝑒𝑖𝑛](𝑀)∗𝑛
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Absorption of the circularly polarised light in the far UV region (180-250 nm) is 
owed to excitation of electronic transitions in the amide groups arising from the peptide 
bonds in the protein’s backbone (230). Different structural motifs of the peptide 
backbone, such as α-helices and β-sheets, have distinctive dihedral angles and 
patterns of hydrogen bonding which, in turn, result in distinctive CD spectra (264). 
Typical spectra for proteins in aqueous solution with different secondary structures are 








Proteins with α-helices, such as C45, exhibit a characteristically double-dip 
shaped spectrum with a strong positive band between 190 nm and 200 nm and two 
strong negative bands at 208 nm and 222 nm. The maximum as well as the minimum 
at 208 nm are attributed to π→π* transitions and the strong negative band at 222 nm 
to n→π* transitions (260, 265). In β-pleated proteins, a similar maximum between 190 
nm and 200 nm can be observed, also arising from a π→π* transition, with n→π* 
transitions causing a minimum at approximately 215-218 nm (265, 266). The different 
spectra are owed to the dihedral angles in the protein backbone (α: −57°, −47°; β: 
−120°, +120°) which differ in magnitude and direction between the two secondary 
structural motifs (260, 267). Generally, signals in the range of 190 nm to 240 nm arise 
from transitions within the peptide bond (260).  
 
Figure 3.2: Example of CD spectra of proteins with different secondary structures.  
The red spectrum is that of a predominantly α-helical bundle, the blue spectrum is of a β-barrel and the 
green spectrum belongs to a protein exhibiting mixtures of the aforementioned motifs as well as 
unordered structure. The structure of each protein is visualised in the same colour as the corresponding 
spectrum for reference. Figure taken from (268). 
 




  Expression and purification of C45 
C45 was expressed in E. coli with a 6-histidine tag and purified using nickel affinity 
chromatography, TEV cleavage, further nickel affinity chromatography and size 
exclusion chromatography. The latter type of chromatography can separate proteins 
by size and provide some information about the quarternary structure of the protein. 
The chromatogram indicating the elution of three peaks is shown in Figure 3.3. 
Fractions were taken at different points during the elution and analysed using UV-
visible spectroscopy, which can indicate the samples’ heme content. The UV-visible 
spectra shown in Figure 3.4 a, where each spectrum is shown in the colour that was 
also used to show the chromatography fraction it corresponds to in Figure 3.3.  
 
Figure 3.3: Chromatogram from size exclusion chromatography showing the absorbance at 280 nm.  
Coloured fractions were analysed via UV-visible spectroscopy.
3.2. Results - Expression and purification of C45 
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The fractions from the first elution exhibit a small absorption in the region of the 
Soret band, compared to the strong peak at 280 nm. The low heme content in these 
fractions is likely due to apoprotein, suggesting incomplete heme incorporation by the 
cytochrome c maturation apparatus.  
The lower absorbing region eluting between the first and the second peak on the 
chromatogram shows a clearly visible Soret band, potentially caused by C45 
aggregates. The red shifted Soret band indicates a hexacoordinate heme iron (269). 
This could mean the metal coordinates some species present in the buffer, such as 
imidazole. It is unlikely, however, that this was bound to the heme sufficiently tightly to 
avoid removal by size exclusion chromatography. A more plausible alternative is that 
the protein is present in oligomeric form and heme bis-histidine ligated between two 
binding sites.  
The second and third elution peaks contain C45. Since oligomerisation had 
previously been observed in maquette proteins (270), it is likely that the enzyme is 
present in dimeric (second peak) and monomeric (third peak) forms. All fractions from 
these elution peaks were pooled. 
C45 was characterised during each step of the protocol using UV-visible 
spectroscopy and SDS-PAGE. Samples were taken of the cell pellet, the lysate, after 
the addition of TEV protease as well as after each run of chromatography. The gel 
(Figure 3.4 b) clearly demonstrates the effectiveness of the purification process: the 
cell pellet and lysate (Lanes A and B) contain a multitude of intracellular proteins, as 
indicated by the numerous blue bands. Nickel affinity chromatography removes the 
vast majority of these, which, in contrast to C45, do not bind tightly to the nickel resin 
(Lane C). However, multiple bands are still visible: the band at just over 15 kDa 
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corresponds to the His-tagged C45. After the addition of TEV protease (Lane D), this 
band is visible further down the gel, as the cleavage resulted in a smaller protein. The 
second round of nickel affinity chromatography removes TEV protease, the cleaved 
histidine tag and any protein impurities which bind the nickel resin as indicated by a 
lack of bands in Lane E. The last two lanes (F and G) correspond to peak 1 of the size 
exclusion chromatography and the pooled fractions of peak 2 and 3, respectively. The 
first peak to elute during the chromatography shows not a single clear band, but a 
mixture of low intensity bands of all masses. This band confirms the presence of 
several impurities. The final sample of C45 used for further protein work, on the other 
hand, clearly shows a single visible band at 15 kDa (Lane G). 
Expressions yielded approximately 2.4 mg C45 per litre expression culture. This 
concentration was determined from absorption at 406 nm, where C45 has a known 
extinction coefficient of 147,300 M−1 cm−1 (2). Importantly, this will only account for 
holoprotein, as any apoprotein (where the heme cofactor was not incorporated) would 
not absorb at this wavelength. Consequently, it is possible that protein concentrations 
were larger than estimated, however, it is unlikely that apoprotein is catalytically active. 





Figure 3.4: Analysis of C45 at different stages of its purification and different chromatography fractions. 
 a - UV-visible spectra of the fractions taken from size exclusion chromatography (see Figure 3.3). Colours 
correspond to the matching coloured fractions in the chromatogram, which is inset on the right side for 
reference. Samples were not concentrated or diluted, except for the two dashed spectra, for which the 
samples were diluted 1:5.  
b - SDS-PAGE Gel showing C45 at different stages during the purification process. A – Cell pellet. B – 
Supernatant after sonication and centrifugation of cell pellet. C – post nickel affinity chromatography prior 
to TEV cleavage. D – post addition of TEV protease. E – post nickel affinity chromatography after TEV 
cleavage. F – peak one from size exclusion chromatography. G – 2nd and 3rd peak from size exclusion 
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  Pyridine Hemochrome 
The pyridine hemochrome of C45 (Figure 3.5) confirmed the presence of cofactor 
heme, which corresponds to the Soret band seen at 409 nm and 413 nm in oxidised 
(ferric) and reduced (ferrous) protein, respectively. It reproduces the expected spectra 
for c-type cytochromes. The location of the Q-bands at 520 nm and 551 nm for ferrous 
heme are typical for a protein binding heme C (227). 
 
Figure 3.5: Pyridine hemochrome of C45. 
 
  UV-visible spectroscopy 
C45 was analysed by UV-visible spectroscopy to probe the chemical environment 
of heme in increasing concentrations of cosolvents. The spectrum of C45 in buffer 
(Figure 3.6 a) indicates that the iron within the protein is primarily in the ferric (+3) 
oxidation state. The Soret band is clearly visible at 405 nm.  
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UV-visible absorption spectra were also taken of C45 in various solvents (Figure 
3.6 b-f). The location of the Soret peak at different protein concentrations is shown in 
Figure 3.7. In methanol, ethanol and TFE, the Soret peak occurs at decreasing 
wavelengths as cosolvent concentration is raised. In isopropanol and acetonitrile no 
clear trend is observed, although repeat measurements may be beneficial. Changes 
in Soret band location are likely related to the electrostatic field the protein is exposed 
to, which changes with the addition of cosolvent (271). In all cosolvents, however, the 
Soret peak is located below 408 nm, implying mono-histidine ligation of heme.  
In high (70-80%) concentrations of acetonitrile, ethanol and isopropanol, 
scattering was observed as indicated by the significant increase of baseline 
absorption. This also led to a slight shift in location of the Soret band. In line with the 
scattering observed, the solutions appeared turbid. Surprisingly, this effect diminishes 
over time (Figure 3.8). For instance, the spectrum of C45 in 80% TFE remains 
unchanged over an incubation period of several hours, whereas the corresponding 
spectrum in 80% ethanol shows significantly less scattering after five hours. This may 
indicate resolvation of C45 in the aqueous-organic solution over time. 
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Figure 3.6: UV-visible absorption spectra of C45 in aqueous-organic solutions. 
C45 in solutions containing no cosolvent (a) or varying amounts of acetonitrile (b), ethanol (c), isopropanol 
























Figure 3.8: Declining scattering of C45 in 80% ethanol compared to 80% TFE. 
UV-visible absorption spectra of C45 in 80% ethanol (a) and 80% TFE (b) immediately after mixing and 
after an incubation time, during which the scattering in the ethanol solution reduces and the spectrum in 
TFE remains. 
 
  Circular Dichroism of C45 at room temperature 
Further analysis of the protein involved room temperature CD spectroscopy in 
buffer and cosolvents (Figure 3.9), which can indicate the presence of some motifs of 
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exhibits the features characteristic of α-helices, namely a maximum at approximately 
197 nm and minima at 208 nm and 222 nm (44, 272). Generally, the data obtained at 
wavelengths below 200 nm are associated with higher errors due to large high-tension 
(HT) voltages at lower wavelengths. This leads to lower signal to noise ratios (273). 
Most of the analysis herein will therefore focus on the minimum at 208 and especially 
the minimum located at approximately 222 nm, with samples prepared and 
experiments performed as described in section 2.2.7. 
In up to 60% of all cosolvents as well as 70% ethanol and up to 80% methanol 
and TFE, the CD spectra still clearly display this shape. This conveys that in these 
cosolvent concentrations, C45 is predominantly helical. In 70-80% acetonitrile, 80% 
ethanol and 70-80% isopropanol, however, this is not the case anymore and the 
protein appears to be denatured.  
A comparison of the intensities of the peaks in different cosolvent concentrations 
(Figure 3.10) shows that the signal intensity for both minima is consistent in solutions 
with up to 60% acetonitrile. In all other cosolvents – the four alcohols – this signal 
increases along with cosolvent concentration for the non-denatured protein. This 
suggests a higher degree of helicity, which had previously been observed in alcohols 
and especially in TFE (3). This trend may, however, be slightly exaggerated here as 
the concentration of enzyme in the solution may be slightly larger in higher alcohol 
concentrations, as the addition of alcohol and water can lead to a smaller volume than 
the sum of the two volumes added (274).  







Figure 3.9: Room temperature CD spectra of C45 in aqueous solution with organic cosolvents. 
C45 in aqueous solution and (a) varying amounts of acetonitrile (b), methanol (c), ethanol (d), isopropanol 
(e) and TFE (f). The spectrum in buffer (a) indicates a well-folded α-helical protein. The other spectra show 
that this protein is stable in up to 60% isopropanol and in up to 70% ethanol and acetonitrile. No loss of 


















Figure 3.10: Molar residue ellipticity of C45 in increasing cosolvent concentrations. 
Θ at (a) the minimum at approximately 208 nm and (b) the minimum at approximately 222 nm, 
characteristic for helical proteins. The signal intensifies with increasing concentrations of alcohol and is 
consistent in acetonitrile, except in cosolvent concentrations where the protein is denatured (70-80% 
acetonitrile, 70-80% isopropanol, 80% ethanol). 
 
  CD Thermal denaturation studies 
3.2.5.1. Thermal denaturation of C45 in buffer 
To probe the enzyme’s thermostability, C45 was analysed using variable 
temperature circular dichroism (CD) spectroscopy. The protein was heated from 8 °C 
to 85 °C at a rate of 1 °C per minute, with ellipticity constantly monitored at 222 nm 
(Figure 3.11 a), a minimum for α-helical proteins, as seen in Figure 3.9 a.  
The thermal denaturation curve (Figure 3.11 a) can be split into two sections: 
Initially, the increase in ellipticity is gradual, indicating a non-cooperative loss of 
helicity. In line with literature, this occurs most likely in the form of fraying at the termini 
of the α-helices (3). However, once elevated to above 64 °C, the steeper curve 
suggests that the protein denatures more cooperatively. This alludes to the enzyme 
simultaneously unfolding at multiple sites at higher temperatures, possibly around the 
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Figure 3.11: CD thermal denaturation spectra of C45 in buffer.  
a - Molar residue ellipticity measured at 222 nm during the heating and subsequent re-cooling process. 
The overlapping curves indicate that thermal denaturation of the protein is reversible. Grey line 
superimposed for visualisation only. b - Full spectra of the sample at various, discrete temperatures 
showing good thermostability of the protein in buffer 
 
A further interesting observation is the refolding profile of C45. After thermal 
denaturation, cooling was immediately initiated, and the refolding process assessed 
using CD. This trace, also monitored at 222 nm, is displayed as a dotted line in Figure 
3.11 a, which overlaps with the heating curve, meaning the thermal denaturation of 
C45 is entirely reversible and the protein spontaneously refolds again.  
CD spectra obtained at different points during the experiment (Figure 3.11 b) also 
clearly convey the thermal denaturation and refolding, as indicated by overlapping 
spectra prior to and after the experiment. Furthermore, the ratio between ellipticity 
values at 222 nm and 208 nm decreases. This is sometimes seen as an additional 
marker of helicity, with high ratios (>1) suggesting a tight, coiled structure and lower 
ratios isolated helices or even denatured helices (275, 276). The decreasing ratio 
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Unfortunately, no definite conclusions can be drawn from these results about 
folding mechanisms and cooperativity. It would be interesting to be able to heat the 
enzyme to a higher temperature to fully observe the denaturation. However, since 
ellipticity is heavily concentration dependent, it is crucial to avoid solvent evaporation 
which could lead to false or misleading data which is why heating was terminated at 
85 °C and the cuvette sealed. An alternative technique to measure the unfolding of 
C45 would be CD in the presence of a denaturant or a titration with guanidine 
hydrochloride (277). 
3.2.5.2. Thermal denaturation of C45 in Acetonitrile 
CD thermal denaturation studies were also performed in 10-80% acetonitrile and 
ellipticity monitored at 222 nm (Figure 3.12 and Figure 3.13 a). Grey lines are overlaid 
to show the initial, linear phase of unfolding, and the temperature at which folding 
becomes more cooperative.  
Due the boiling point of acetonitrile being lower than that of water, the heating of 
C45 had to be terminated at a lower temperature, at 70 °C as opposed to 85 °C. The 
thermal denaturation curves of C45 in acetonitrile show that in 10% acetonitrile C45 
unfolds similarly as it does in buffer, with some degree of cooperativity suggested by 
the steepening of the curve above 60 °C. In 20-30% acetonitrile, this change in curve 
gradient is still observable, but at lower temperatures (50 °C and 40 °C, respectively) 
suggesting that the enzyme loses thermostability in increasing cosolvent 
concentrations. In higher acetonitrile concentrations, unfolding is even more 
cooperative. 







Figure 3.12: CD scan of C45 in aqueous solution with acetonitrile during heating and cooling. 
C45 in buffering solution containing 10% (a), 20% (b), 30% (c), 40% (d), 50% (e), 60% (f), 70% (g) and 80% 
(h) acetonitrile. In up to 60% acetonitrile concentration, thermal denaturation is reversible. Grey lines 






















Figure 3.13: Thermal denaturation curves of C45 in aqueous solution with acetonitrile. 
a – Overlay of thermal denaturation curves (monitored at 222 nm) in all acetonitrile concentrations 
tested. b– Ellipticity at 8 °C showing no change in acetonitrile concentrations of up to 60%. c-Difference 
in ellipticity 222 nm of C45 in increasing acetonitrile concentrations between 8 °C and 70 °C. 
 
In 40-60% acetonitrile, the change in gradient cannot be observed, but the overall 
shape of the curve is steeper, indicating more cooperative unfolding, though at the 
starting temperature, θ is similar (-37,000 to -42,000 deg cm2 d mol-1), as shown in 
Figure 3.13 b. In all of these acetonitrile concentrations, C45 completely refolds. 
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up to 60%, indicating C45 retains its secondary structure well even in cosolvent and 
at temperatures of up to 70 °C.  
In 70% acetonitrile, molar residue ellipticity at 8 °C is at approximately -4200 deg 
cm2 d mol-1, suggesting that there is a significant loss of secondary structure. During 
the course of heating and the subsequent cooling, this value decreases to 
approximately -11,000 deg cm2 d mol-1. In 80% acetonitrile, the protein is entirely 
denatured with no secondary structure present. 
Figure 3.13 c shows the difference in ellipticity at 222 nm between the initial and 
final temperatures of 8 °C and 70 °C indicating the loss of secondary structure between 
those temperatures. The data suggest that in 20-60% acetonitrile the loss of 
secondary structure is larger than in buffer or 10% acetonitrile, indicating that C45 is 
less thermostable in those concentrations. In higher acetonitrile concentrations, C45 
is either denatured or precipitated or a mixture. 
The theory that C45 loses thermostability in increasing acetonitrile concentrations 
is also supported by the ellipticity at 222 nm monitoring loss of helicity, as well as the 
full spectra obtained at various points throughout the heating process (Figure 3.14). In 
10-20% acetonitrile, the spectrum at 70 °C does not exhibit the two minima typical of 
helical proteins, similar to the spectrum in buffer at 75 °C. The spectrum in buffer at 
55 °C, however, does still display this typical shape with a maximum at 197 nm and 
minima at 208 nm and 222 nm. In acetonitrile concentrations of 30% or above, on the 
other hand, the spectra obtained at 50 °C do not follow this shape, suggesting some 
loss of helicity.  
The general trend of declining thermostability of the protein in increasing 
acetonitrile concentration is not unanticipated. However, the decreasing ellipticity 
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during the heating of C45 in 70% acetonitrile was intriguing and the experiment was 
repeated multiple times (Figure 3.15). Once reproducibility of the data was 
established, this result was probed further. At the start of a melting experiment, the 
sample is usually cooled rapidly to the starting temperature. In order to probe whether 
this initial cooling of the sample at a high and uncontrolled rate was responsible for 
some form of denaturation of the protein, the initial cooling rate was set to 0.5 °C per 
minute. This was also used as the rate for heating and cooling to establish whether 
the increased helical signal after cooling is related to the heating rate. However, 
despite the slower heating of the sample, the phenomenon of increased helicity after 
heating and cooling was observed again. The same sample was then re-heated and 
re-cooled twice more at 0.5 °C per minute. While for the second and third cooling cycle 
the signal became weaker during the heating process, the trend of increased ellipticity 
upon complete re-cooling, as opposed to the initial measurement at the same 
temperature prior to heating was consistent and reproducible. The minor solvent loss 
(not above 10% volume) alone cannot account for the observed increase in molar 
residue ellipticity with heating and cooling of the protein solution. 
Even though both the melting curves and the full CD spectra at various 
temperatures (Figure 3.15 b) seem to suggest an increase in helix stability upon 
heating and re-cooling, this is unlikely. It is more conceivable that some precipitation 
of enzyme occurred during the rapid addition of cosolvent which was at least partially 
reversed during the heating process, raising the concentration of C45 on which CD 
results are very dependent. This suggests that in 70% acetonitrile C45 retains at least 
some of its secondary structure, which however is only observable when the solution 
is thoroughly mixed without any precipitation.  







Figure 3.14: CD spectra of C45 in aqueous solution with acetonitrile during heating and re-cooling. 
C45 in aqueous solution containing 10% (a), 20% (b), 30% (c), 40% (d), 50% (e), 60% (f), 70% (g) and 80% 






















Figure 3.15:  CD measurements of C45 in buffering solution with 70% acetonitrile.  
a - θ at 222 nm during three cycles of heating and cooling at a rate of 0.5 °C per minute after initially being 
cooled from room temperature to 8 °C at the same rate (labelled “initial cool”). b - Full CD spectra taken 
during the first heating phase and when re-cooled and re-heated. 
 
3.2.5.3. Thermal denaturation of C45 in Methanol 
The same method was used to probe the effects of methanol, the smallest 
possible alcohol, on the structure and thermostability of C45, though due to methanol’s 
lower boiling point, heating was terminated at 55 °C. The continuous scans at the 
minimum of 222 nm (Figure 3.16) shows that at the initial temperature of 8 °C, the 
ellipticity decreases from -37,000 deg cm2 dmol-1 to approximately -50,000 deg cm2 
dmol-1 with increasing methanol concentration (Figure 3.17). This is likely to be 
indication of an increase in helicity, but is probably overestimated due to the decrease 
in volume of methanol-water mixtures which would effect a higher protein 
concentration in the sample and thus a stronger CD signal.  
With increasing methanol concentration, the potentially more cooperative phase 
of unfolding occurs at earlier temperatures: While not observable up to the maximum 
measured temperature of 55 °C in up to 40% methanol, cooperative unfolding begins 
at 47 °C and 41 °C for C45 in 50% and 60% methanol, respectively. In higher methanol 
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than in buffer or low methanol concentrations. This is particularly obvious in the overlay 
of the thermal denaturation curves (Figure 3.17 a). Figure 3.17 b and c show the 
general trend of decreasing ellipticity at the starting temperature (8 °C), but increasing 
differences in ellipticity between 8 °C and 55 °C with rising methanol concentration, 
highlighting the more cooperative nature of unfolding in higher methanol 
concentrations. Nonetheless, at 55 °C, molar residue ellipticity in higher methanol 
concentrations is lower, suggesting that even at this temperature, the cosolvent 
stabilises the protein’s secondary structure, but not to the same extent as it does in 
low temperatures. 
No melting temperature could be clearly observed in any methanol concentration. 
Furthermore, the protein refolds completely in all methanol concentrations.   







Figure 3.16: CD scan of C45 in aqueous solution with methanol during heating and cooling. 
MRE (Θ) at 222 nm of C45 in buffering solution containing 10% (a), 20% (b), 30% (c), 40% (d), 50% (e), 
60% (f), 70% (g) and 80% (h) methanol showing that thermal denaturation of the enzyme is reversible. 






















Figure 3.17: Thermal denaturation curves of C45 in aqueous solution with methanol. 
a – Overlay of thermal denaturation curves (monitored at 222 nm) in all methanol concentrations tested. 
b– Ellipticity at 8 °C showing a decrease with increasing methanol concentration. c-Difference in ellipticity 
222 nm of C45 in increasing methanol concentrations between 8 °C and 55 °C. 
 
Full spectra of C45 in methanol-water mixtures taken at various points throughout 
the heating and cooling process seem to confirm that the protein only experiences 














Figure 3.18:  CD spectra of C45 in aqueous solution with methanol. 
Full CD spectra at various temperatures during the heating and re-cooling of C45 in aqueous solution 
containing 10% (a) and 20% (b), 30% (c), 40% (d), 50% (e), 60% (f), 70% (g) and 80% (h) methanol showing 
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3.2.5.4. Thermal denaturation of C45 in Ethanol 
The same methods were used to investigate the enzyme’s secondary structure in 
ethanol-water mixtures, with the slight exception that temperature was raised to 65 °C 
(Figure 3.19 and Figure 3.20 a). Up to this temperature, the enzyme does not show 
complete thermal denaturation in up to 70% ethanol. The loss in helicity that is 
observed is entirely reversible upon cooling.  
Similar to the results in methanol, the negative band at 222 nm appears to get 
stronger with increasing ethanol concentration at 8 °C (Figure 3.20 b). Like in 
methanol, this is likely not exclusively owed to increasing helicity, but also influenced 
by the volume of ethanol-water mixtures being smaller than the sums of the two 
volumes mixed (274). Furthermore, thermal denaturation curves become steeper as 
cosolvent concentration increases, suggesting a lowering of thermostability (Figure 
3.20 c). It is also notable that the cooperative phase of unfolding begins at lower 
temperatures as ethanol concentration is raised, until the entirety of unfolding 
proceeds more cooperatively at 60% and 70% ethanol. 
The exception to this trend is the scan in 80% ethanol, which is approximately -
5,000 deg cm2 dmol-1 at 8 °C and exhibits decreasing molar residue ellipticity as 
temperature is raised. This experiment was repeated, with an increased number of 
heating and cooling cycles (Figure 3.22 a and b). In another repeat, the experiment 
was performed with a controlled, slow cooling before commencement of the 
experiment as well as a rate of heating of 0.5 °C per minute (Figure 3.22 c and d). 
The trend of decreasing ellipticity with ascending temperature is consistent. Akin to 
temperature wavelength scans in 70% acetonitrile, this was attributed to protein 
precipitation which was reversed during heating.  







Figure 3.19: CD scan of C45 in aqueous solution with ethanol during heating and cooling. 
Mean residue molar ellipticity (Θ) at 222 nm of C45 in aqueous solution containing 10% (a), 20% (b), 30% 
(c), 40% (d), 50% (e),60% (f) ,70% (g) and 80% (h) ethanol indicating that in solutions of up to 70% ethanol 























Figure 3.20: Thermal denaturation curves of C45 in aqueous solution with ethanol. 
a – Overlay of thermal denaturation curves (monitored at 222 nm) in all ethanol concentrations tested. 
b– Ellipticity at 8 °C showing a decrease with increasing ethanol concentration. c-Difference in molar 
residue ellipticity at 222 nm of C45 in increasing ethanol concentrations between 8 °C and 65 °C. 
 
 
Full CD spectra of C45 in increasing ethanol concentration (Figure 3.21), like the 
continuous scans at 222 nm, also suggest that in up to 70% ethanol, the enzyme only 















Figure 3.21: CD spectra of C45 in aqueous solution with ethanol. 
Full CD spectra at various temperatures during the heating and re-cooling of C45 in buffering solution 
containing 10% (a), 20% (b), 30% (c), 40% (d), 50% (e), 60% (f), 70%  (g) and 80% (h) ethanol showing that 






















Figure 3.22: CD measurements of C45 in buffering solution with 80% ethanol.  
a and c show the MRE at 222 nm during multiple cycles of heating and cooling at a rate of 0.5 °C per 
minute after initially being cooled from room temperature to 8 °C at the same rate. b and d show full CD 
spectra taken during the first heating phase and when re-cooled and re-heated. 
 
 
3.2.5.5. Thermal denaturation of C45 in Isopropanol  
To investigate the effects of a slightly bulkier alcohol on the folding and 
thermostability of C45, the enzyme was analysed in different concentrations of 
isopropanol using CD temperature scans up to 70 °C (Figure 3.23 and Figure 3.24 
a). Figure 3.25 shows full CD spectra at various temperatures. In up to 60% 
isopropanol, scans suggest C45 possesses its native secondary structure at 8 °C, with 
molar residue ellipticity values at 222 nm ranging from -37,000 to -52,000 deg cm2 
dmol-1 (Figure 3.24 b). As in methanol and ethanol, they decrease with increasing 
isopropanol concentration (up to 60%), likely for the same mixture of increasing helicity 
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rising temperature – increasingly so at increasing isopropanol concentrations (Figure 
3.24 c) – however not sufficiently so that a melting temperature could be calculated. 
As seen in other cosolvents, the cooperative phase of unfolding is initiated at lower 
temperatures with increasing isopropanol concentrations, until no change in 
cooperativity is observed anymore and the entire process appears to occur much more 
cooperatively than in buffer. Furthermore, C45 also refolds entirely upon cooling in all 
these isopropanol concentrations. 
In 70% isopropanol, the scan showed similarities with those in 70% acetonitrile 
and 80% ethanol: initially, the molar residue ellipticity is significantly higher 
(approximately -7,000 deg cm2 dmol-1). This observation was attributed to precipitation 
and resolvation, as in 70% acetonitrile and 80% ethanol. The experiment was repeated 
with a less steep temperature elevation (0.5 °C per minute) and just like in 80% 
ethanol, this improved resolvation (Figure 3.26). 
In 80% isopropanol, the secondary structure appears to be denatured, however 
this is independent of temperature with a positive molar residue ellipticity at 222 nm at 
the initial temperature of 8 °C. 
  







Figure 3.23: CD scan of C45 in aqueous solution with isopropanol during heating and cooling. 
Mean residue molar ellipticity (Θ) at 222 nm of C45 in buffering solution containing 10% (a), 20% (b), 30% 
(c), 40% (d), 50% (e), 60% (f), 70% (g) and 80% (h) isopropanol conveying that in up to 60% isopropanol, 























Figure 3.24: Thermal denaturation curves of C45 in aqueous solution with isopropanol. 
a – Overlay of thermal denaturation curves (monitored at 222 nm) in all isopropanol concentrations 
tested. b– Molar residue ellipticity at 8 °C showing a decrease with increasing isopropanol concentration. 














Figure 3.25: CD spectra of C45 in aqueous solution with isopropanol. 
Full CD spectra at various temperatures during the heating and re-cooling of C45 in buffering solution 
containing 10% (a), 20% (b), 30% (c), 40% (d), 50% (e), 60% (f), 70% (g) and 80% (h) isopropanol showing 





















Figure 3.26: CD measurements of C45 in buffering solution with 70% isopropanol. 
 a – Molar residue ellipticity at 222 nm during multiple cycles of heating and cooling at a rate of 0.5 °C per 
minute after initially being cooled from room temperature to 8 °C at the same rate. b - Full CD spectra 
taken during the first heating phase and when re-cooled and re-heated. 
 
3.2.5.6. Thermal denaturation of C45 in TFE 
CD was also used to investigate the thermostability and folding of C45 in solutions 
of 10-80% TFE (Figure 3.27). Previous work on helical proteins has shown that TFE 
stabilises helices (4). The secondary structure of C45 was therefore expected to 
clearly exhibit a helical secondary structure in temperatures up to at least 55 °C, 
similarly to aqueous solution. This was experimentally confirmed: up to a temperature 
of 70 °C, C45 retained its secondary structure in solutions with up to 80% TFE. In all 
investigated TFE concentrations, the enzyme loses helicity with increasing 
temperatures, however no indication of different phases with distinct levels of 
cooperativity can be observed in the denaturation process, nor has the protein been 
observed to fully denature in temperatures up to 65 °C. As in other cosolvents, any 
loss of secondary structure is entirely reversible in all TFE concentrations tested.  
As predicted by the literature, the helicity of C45 increases with TFE 
concentrations, especially at the lowest temperature of 8 °C (Figure 3.28 b). Even at 
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stabilising properties of the cosolvent. The signal increase with TFE addition is larger 
at lower temperatures, though, suggesting unfolding proceeds more cooperatively at 
higher TFE concentrations. This is in agreement with the literature, which states that 
the helix stabilising properties are known to be particularly observable at low 
temperatures (3).  
It has been suggested that the ellipticity at the minimum at 222 nm should be 
approximately -44,000 deg cm2 d mol-1 for an infinite helix at 0 °C (148). At TFE 
concentrations above 30%, however, the experimentally measured minimum at 222 
nm was lower for C45 at the starting temperature of 8 °C (Figure 3.28 b). Luo et al., 
who proposed the aforementioned limit of -44,000 deg cm2 d mol-1, saw no further 
increase in protein helicity at TFE concentrations above 25%, which is very different 
from the results obtained for C45. Furthermore, their research did not involve work 
with TFE concentrations above 50%. It is therefore unclear how higher TFE 
concentrations affect the minimal value for ellipticity at 222 nm for a fully helical protein. 
Nonetheless, the discrepancy between this value and the measurements for C45 
in TFE may indicate significant experimental error, potentially due to an 
underestimation of protein concentration. This was calculated from absorbance in the 
heme region, signifying that any apoprotein would not be taken into account, resulting 
in an underestimation of protein concentration and thus an overestimation of the 
concentration-dependent ellipticity.  
Spectra of C45 in TFE-aqueous mixtures obtained at increasing temperatures 
(Figure 3.29) confirm that the protein loses some helicity as temperature is elevated 
but refolds completely upon cooling. The protein appears to be helical in all TFE 
concentrations. 







Figure 3.27: CD scan of C45 in aqueous solution with TFE during heating and cooling. 
Mean residue molar ellipticity (Θ) at 222 nm during heating and cooling of C45 in aqueous solution 
containing 10% (a), 20% (b), 30% (c), 40% (d), 50% (e), 60% (f), 70% (g) and 80% (h) TFE showing that 























Figure 3.28: Thermal denaturation curves of C45 in aqueous solution with TFE. 
a – Overlay of thermal denaturation curves (monitored at 222 nm) in all TFE concentrations tested. b– 
Ellipticity at 8 °C showing a decrease with increasing TFE concentration. c-Difference in ellipticity 222 nm 















Figure 3.29: CD spectra of C45 in aqueous solution with TFE. 
Full CD spectra at various temperatures during the heating and re-cooling of C45 in buffering solution 
containing 10% (a), 20% (b), 30% (c), 40% (d), 50% (e), 60% (f), 70% (g) and 80% (h) TFE indicating good 





















In this chapter the structural properties of C45 and the effects of different 
cosolvents on these were investigated. It has been shown that the C45 purification 
protocol is suitable to remove the vast majority of intracellular proteins, apoprotein, 
aggregates and other impurities to yield sufficiently pure C45. The protein elutes from 
size exclusion chromatography in two peaks on size exclusion chromatography, which 
suggests a degree of dimerisation. While it was confirmed with SDS-PAGE that both 
peaks correspond to C45, the technique is not capable of distinguishing between 
monomers and dimers. Techniques such as dynamic light scattering, small angle x-
ray scattering or native PAGE would be better suited for this.   
UV-visible spectroscopy of the purified protein clearly indicated the presence of 
heme, and a room temperature CD spectrum showed that the enzyme is strongly α-
helical. This conveys that after the expression and purification, the protein is correctly 
folded and binding the catalytic heme cofactor, which is mono-histidine ligated. 
Furthermore, variable temperature CD indicated that the protein only partially unfolds 
at temperatures of up to 85 °C, implying good thermostability in agreement with the 
literature (2). This proved to be entirely reversible. The thermal denaturation curve 
showed that at temperatures above 65 °C, unfolding proceeds more cooperatively, 
which is very common in helical bundle proteins (277–279). However, this is neither 
pronounced strongly enough, nor can the protein be thermally unfolded completely in 
temperatures up to 85 °C, which would be necessary to reliably quantify this 
behaviour. Chemical unfolding using, for instance, guanidine hydrochloride may 
provide an alternative route to investigating the unfolding process of C45. 
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Further, analytical data are presented for C45 in varying concentrations of 
acetonitrile, methanol, ethanol, isopropanol and TFE. In concentrations up to 60% 
acetonitrile and isopropanol, up to 70% ethanol, and up to the highest tested 
concentration of 80% methanol and TFE, the protein appears to retain its mono-
histidine ligated heme as a cofactor as well as its secondary structure at room 
temperature. In higher concentrations of acetonitrile, ethanol and isopropanol, the 
protein appears to have lost its secondary structure and be entirely denatured. 
Whether there is a correlation between solvent polarity and cosolvent concentration, 
at which the protein denatures would require further testing with a larger range of 
cosolvents, however the data presented herein suggest this may be the case.  
The loss of structural stability upon an increase in temperature as well as the 
presence of high concentrations of some cosolvents (70% isopropanol and 80% 
ethanol) can also be seen in the decreasing ratio of ellipticity at 222 nm and 208 nm. 
In all solvents, a clear decrease in this ratio can be seen, suggesting a less tightly 
packed and overall less helical protein upon application of heat.   
Interestingly though, with the addition of the alcoholic cosolvents in lower 
concentrations than those causing denaturation, the degree of helicity appears to 
increase (Figure 3.30), especially with TFE. Alcohols as cosolvents – and TFE in 
particular - had previously been shown to stabilise helices (3). However, this effect 
may be exaggerated in the data presented here as volumetric reduction caused by the 
addition of alcohols to water may lead to underestimation of protein concentration 
values. Furthermore, the protein concentration was determined from absorbance at 
406 nm, which is dependent on the successful incorporation of heme into the protein 
scaffold. The presence of any apoprotein, however, would not be mathematically taken 




concentration. It is, however, worth noting that the same quantity of C45 from the same 
expression batch was added to each of the experiments, so an underestimation of 
protein concentration would lead to an overestimation of ellipticity at 208 and 222 nm 
in all experiments and not exclusively those performed in high solvent concentrations. 
 
Figure 3.30: Molar residue ellipticity at 222 nm at 8 °C for C45 in various cosolvents.  
 
TFE increases the helical propensity of amino acids. Nonetheless, glycine, which 
is a key component of the loops between the helices in C45, still acts as a so-called 
helix breaker (3). Therefore, it is less likely that helicity increases due to helical 
propagation through the loops than there being an equilibrium between the helical and 
the random coil states of the protein which is shifted towards the helix with the addition 
of TFE and other alcohols.  
Furthermore, the distinction between secondary and tertiary structure is crucial. 
While CD can provide insights into the helicity of C45, it can only provide very limited 
insights into the tertiary structure. TFE has, for instance, been demonstrated to 
propagate helicity in proteins even at the cost of tertiary structure (141). It is possible, 
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that with the addition of cosolvents, the protein retains its helical structure or even 
increases in helicity, but is otherwise unfolded (Figure 3.31). Therefore, no conclusion 
can be drawn regarding the functionality of the enzyme from the helicity. 
 
Figure 3.31: Models for a four helix bundle protein with the same levels of helicity, but different tertiary 
structure. 
 
Variable temperature CD studies of C45 in cosolvents showed that C45 lost 
helicity with increasing temperature, however, not to the extent that the protein 
denatures completely. Therefore, very little can be concluded about the protein’s 
unfolding profile. Repeat experiments with the addition of a chemical denaturant or 
titrations with guanidine hydrochloride may be pertinent to obtain an unfolding profile. 
Nonetheless, some insights can be gained from these results. Firstly, it is clear that 
unfolding is entirely reversible in all cosolvents. Secondly, the thermostability of C45 
does not seem to diminish with the addition of alcohols as a cosolvent. Comparison of 
molar residue ellipticity values at 55 °C shows that in most alcoholic cosolvents (except 
for 70-80% isopropanol and 80% ethanol), C45 does not exhibit significantly less 
helicity than in buffer. In acetonitrile, however, ellipticity at this temperature rises with 
increasing cosolvent concentration. This suggests that out of the five cosolvents 
tested, acetonitrile is the only one that significantly decreases thermostability of the 





Figure 3.32: Molar residue ellipticity at 222 nm of C45 in different cosolvents at 55 °C 
 
 In 70-80% acetonitrile and isopropanol as well as 80% ethanol, the protein 
appears entirely denatured and the solutions appeared slightly turbid. Some of the CD 
spectra suggest that an increased degree of helicity is achieved by applying heat to 
the sample, however, this is more likely owed to resolvation of precipitated protein. 
The fact that without the application of heat, the UV-visible spectrum also changed 
with the amount of scattering significantly reducing (indicating fewer aggregates in the 
solution) supports this hypothesis. 
The main conclusion from the data presented in this chapter is that the protein 
appears structurally resilient to the presence of up to at least 60% cosolvent. The 
following chapter will address the impact on peroxidase kinetics that the presence of 





4. Functional characterisation 
of C45 in organic cosolvents 
 
In the previous chapter, the effects of acetonitrile, methanol, ethanol, isopropanol 
and TFE on the protein’s secondary structure were explored. Generally, the addition 
of alcoholic cosolvents, especially TFE, appeared to cause an increase in helix stability 
in C45 whereas acetonitrile had the opposite effect. In high (70-80%) concentrations 
of acetonitrile and isopropanol as well as 80% ethanol, the protein appeared to have 
lost its structure. In lower cosolvent concentrations, however, C45 remained 
predominantly helical, although this does not necessarily mean that the tertiary 
structure remained unaffected. It will be interesting to observe whether the catalytic 
activity of the enzyme is similarly well retained in cosolvent and whether the stabilising 
alcohols will have a positive effect.  
4.1. Introduction 
The c-type heme cofactor of C45 gives rise to its peroxidase activity meaning it 
catalyses the oxidation of substrates using peroxide as the oxidising agent via the 
hypothesised mechanism shown in Figure 4.1.  
In previous work with C45, the optimal pH for this reaction was determined to be 
8.6, as shown in Figure 4.2 (2). Subsequently, the kinetics of this reaction have been 
extensively tested in buffer at room temperature and above. The highest catalytic 
efficiencies were measured at high temperatures (70 °C), which is in good agreement 





Figure 4.1: The hypothesised catalytic cycle of C45 mediated oxidation of ABTS. 
The intermediate compound I is particularly reactive as it is a cationised radical. Preliminary electron 
paramagnetic resonance spectroscopy data have confirmed the presence of a radical tryptophan residue 
in Compound I, most likely W43, which is located very close to the heme (see Figure 1.17). The structure 
of ABTS is shown in Figure 4.4. 
 
Analysis of two substrate reactions is often performed with one substrate at a 
constant concentration. Typically, saturating concentration is chosen to achieve 
pseudo-first order kinetics. In the case of C45, however, which not only has a very 
high KM for peroxide but is also decomposed by the substrate, subsaturating peroxide 
concentration was chosen. Under these conditions, the reaction proceeds via pseudo-
Michaelis-Menten kinetics. 




Figure 4.2: Kinetics of the oxidation of ABTS by C45 and H2O2 at different pH values.  
a – Kinetics at 25 °C of the reaction of 250 nM C45, 100 μM H2O2 and 0-100 μM ABTS in buffer (100 mM 
KCl and 20 mM potassium phosphate, CHES or bis-tris for pH 6.0-8.0, 8.5-9.0 or 10.0-11.0 respectively) 
indicating that the activity is highest at a pH of 8.5. b – v/[E]0 of the reactions at limiting peroxide and 
saturating ABTS concentrations (100 μM H2O2 and 100 μM ABTS)  at different pH values fitted to a bell-
shaped model, showing an optimum pH of this reaction of approximately 8.6 (2). c – Kinetic analysis of 
100 nM C45 with varying concentrations of ABTS and H2O2 at pH 8.6, fitted to a ping-pong steady-state 
kinetic model. d – Kinetics of 100 nM C45 with 100 μM H2O2 and varying ABTS concentrations at pH 8.6 
and increasing temperature, showing that activity increases with temperature. 
Figure reproduced from (2). 
 
In the Michaelis-Menten model (154), the formation of product from the enzyme 
and substrate is viewed as a two-step process, in which the enzyme (E) first forms a 
complex (ES) with the substrate (S), that subsequently undergoes the reaction to 
product (P) that is released from the enzyme (Figure 4.3). The second step is 












the absence of product. Furthermore, the reaction was performed under steady-state 
conditions, meaning that the concentration of the enzyme-substrate complex remains 
constant.  
 
Figure 4.3: The Michaelis-Menten model of enzyme kinetics. 
The diagram highlights the rate constants involved in the two-step reaction between enzyme E and 
substrate P to first form the enzyme-substrate complex ES and then split into enzyme and product P. 
 
The Michaelis-Menten equation describes the relationship between initial reaction 










where kcat is equal to the maximum rate vmax divided by the initial enzyme 
concentration [E]0. The turnover number kcat refers to the number of substrate 
molecules an enzyme converts per unit time. The Michaelis constant KM is the 
substrate concentration where the reaction rate is half of its maximum vmax. kcat/KM is 
referred to as the catalytic efficiency, with the diffusion limit of 108-109 M-1 s-1 (280) 
setting the maximum. 
ABTS (2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) is a prominent model 
substrate for peroxidase assays. It forms an intensely turquoise coloured radical cation 
(281) upon oxidation (Figure 4.4), which allows the monitoring of peroxidase activity 
spectrophotometrically (20).  




Figure 4.4: The C45-mediated oxidation of ABTS in the presence of hydrogen peroxide. 
 
This can be performed on a UV-visible spectrometer, a stopped flow spectrometer 
or a plate reader. All three were utilised for this work and exploited for their respective 
strengths. A UV-visible spectrometer may be the most versatile, providing the options 
of continuous measurement at a single wavelength or full spectra at specific time 
intervals with a simple experimental setup and the possibility to conduct assays in 
small volumes. Absorbance measurements performed on a plate reader are less 
precise, though this method permits the analysis of many different reactions in parallel, 
rendering it ideal for obtaining kinetic data rapidly (282). The plate reader employed is 
equipped with an automated injection system, further facilitating the automation of 
kinetic assays. Neither setup is adequately equipped for the collection of accurate data 
of the start of the reaction (<10 seconds). A stopped flow spectrometer was used to 
measure kinetics at these short timescales.  
This chapter seeks to understand the functional impact of the cosolvents used in 
chapter 3 on C45. To this end, catalytic activity of C45 is analysed in buffer as well as 
10-80% acetonitrile, methanol, ethanol, isopropanol, and TFE. For this work, the 
optimal conditions established in previous work (2) of buffer containing 20 mM CHES 
and 100 mM KCl at pH 8.6 were used and measurements performed at room 
temperature.  




  Michaelis-Menten Kinetics of C45 with low substrate 
concentrations 
4.2.1.1. Peroxidase Kinetics of C45 in buffer 
For the oxidation of ABTS by C45 in the presence of peroxide, the biggest increase 
in absorbance occurs at 405 nm. Whilst this is in the region of the Soret band, at 
protein concentrations of up to 100 nM the absorbance by heme should be below 
0.015, which is negligible compared to the absorbance of the product. For this 
wavelength, ABTS•+ has a known extinction coefficient ε of 36,800 M-1 cm-1 (2, 283).  
Similar to previous experiments, all kinetics in this chapter are performed under 
constant subsaturating H2O2 concentration of 100 μM. The resulting kcat values are 
thus smaller than the maximum kcat expected for full saturation but can importantly be 
used in comparative fashion between different conditions at the same peroxide 
concentration. The concentration of C45 was set to 100 nM C45 and the ABTS 
concentrations used were 8, 16, 32, 64, 128 and 256 μM. For each point, C45 and 
H2O2 were injected using a plate reader into plates containing various amounts of 
ABTS, shaken for five seconds and activity was measured in quadruplicates. The initial 
rate v0 was determined and divided by the enzyme concentration [E]0. These rates 
were plotted against ABTS concentration and the resulting graph fitted to Michaelis-
Menten kinetic parameters using Origin Software.  
To ensure accuracy and investigate batch to batch variation of C45 as well as 
ABTS, this experiment was conducted five times. The graph displayed in Figure 4.5 
uses the averaged values for v0/[E]0 from all experiments. For each experiment, 
Michaelis-Menten kinetics were fitted individually (Table 7.3 in the appendix), 
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highlighting there is no significant variation between different batches of C45 or ABTS. 
The kcat and KM values under limiting peroxide concentrations were calculated by 
averaging the results of the individually calculated parameters (Table 4.1). 
Table 4.1: Kinetic parameters for the oxidation of ABTS by C45 in aqueous solution. 
kcat (s-1) KM (μM) kcat/KM (s-1 μM-1) 
 




Figure 4.5: Michaelis-Menten kinetics of C45 catalysed ABTS oxidation in aqueous solution. 
Kinetics of the oxidation of 8 - 256 μM ABTS by 100 nM C45 and 100 μM H2O2 at 25 °C in buffer fitted to 
Michaelis-Menten kinetics. Five experiments with four repeat measurements of each value were 
performed, results averaged with the standard deviation used as the error bar. Values were fitted to the 
Michaelis-Menten kinetic model.  
 
The error for kcat/KM was calculated using the Gaussian propagation of error (284). 
This states that random errors δx and δy associated with variables x and y used to 
calculate a further variable F propagate to the error δF according to the following 
formula: 






















For 100 nM C45 (determined using the absorption at the Soret peak), 8 – 256 μM 
ABTS, and 100 μM H2O2 in buffer at room temperature, kcat was 0.76 ± 0.07 s-1 and 
KM 24 ± 7 μM. The resultant kcat/KM is 0.03 ± 0.01 s-1 μM-1, all determined under limiting 
H2O2 concentration. This differs from the literature value of 1.16 ± 0.05 s-1 which was 
measured under the same conditions, except for the C45 concentration of 250 nM. In 
most cases, enzyme concentration can be mathematically corrected for in calculation 
of kinetic parameters to produce comparable values. However, in the case of C45, this 
appears not to be true. In chapter 5 a more thorough kinetic investigation can be found 
which shows that in the case of C45, enzyme concentration strongly influences kinetic 
behaviour. The effect of varying peroxide concentration is also probed further in 
chapter 5.    
Generally, the error associated with the calculated kcat is much smaller than that 
of KM. This is due to the high reactivity of compound I leading to rapid inactivation of 
the enzyme. This was particularly evident at low substrate concentrations which 
predominantly affect KM. A much larger number of repeat measurements would have 
to be performed to overcome this. Thus, all analyses will focus only on kcat, while 
effects on KM and kcat/KM will not be discussed due to their substantial errors.  
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Total turnover numbers (Figure 4.6) represent the absolute number of turnovers  
each enzyme performed during the assay and are calculated by dividing the 
concentration of the totally formed product (derived from absorbance difference at 405 
nm) by enzyme concentration. Excitingly, it was observed that total turnover numbers 
increase significantly with rising ABTS concentrations. This is likely related to the 
instability of the radical compound I which rapidly undergoes off-pathway reactions 
that destroy the enzyme (285, 286). Increasing the saturation with ABTS results in 
decreased binding times and favour the oxidation of ABTS over any competing side 
reactions, thereby increasing the total turnover of each enzyme.  
 
 
Figure 4.6: Total turnover numbers for the oxidation of ABTS by C45 and 100 μM H2O2 in aqueous 
solution. 




4.2. Results - Michaelis-Menten Kinetics of C45 with low substrate concentrations 
120 
 
4.2.1.2. Michaelis-Menten Kinetics of C45 in Acetonitrile 
The characterisation of C45 in buffer was the basis for comparison of the enzyme’s 
catalytic behaviour in different solvents. The experiment was repeated in various 
cosolvents at increasing concentrations. Reactants were mixed with 10-80% 
acetonitrile and tested under otherwise equal conditions as the previous experiments 
in buffer (Figure 4.7 a). Michaelis-Menten parameters were determined using Origin 
software for fitting. Resultant values are shown in Figure 4.7 b-c.  
As the concentration of acetonitrile is raised, kcat generally decreases. At 
concentrations of up to 40% acetonitrile, the decline in kcat is limited to approximately 
20%, whereas in 50-60% acetonitrile, the activity is halved. In 80% acetonitrile, the 
enzyme is entirely inactive which is in agreement with the CD results (Figure 3.9) 
showing complete denaturation of the enzyme in 80% acetonitrile. CD spectra of C45 
in lower acetonitrile concentrations do not suggest significant loss of secondary 
structure, however. The functional effect of the cosolvent therefore appears to be more 
pronounced than any structural effects observed by CD. This may be related to the 
lower polarity of the environment which makes substrate desolvation - and thereby 
binding - less favourable. 
There is, however, a clear trend of decreasing total turnover numbers at the 
maximum ABTS concentration of 256 μM with increasing acetonitrile concentration. 
This trend is consistent with the decreasing kcat values. Viewing this alongside the 
structural analyses suggesting that C45 retains its secondary structure in up to 60% 
acetonitrile, this trend may suggest that not the entire enzyme denatures, but the 
active site does. To analyse this theory, further structural characterisation would be 
required, using methods such as NMR. There are likely also effects of the cosolvent 
on the reaction kinetics independent of the enzyme’s structural integrity, such as 
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lowered stabilisation of an intermediate which may hinder the reaction, which could 
also account for the declining total turnover numbers. It is also likely that the cosolvent 
interferes with substrate binding. 







Figure 4.7: Michaelis-Menten kinetics of ABTS•+ formation in acetonitrile. 
Kinetics of the oxidation of 4 - 256 μM ABTS by 100 nM C45 and 100 μM H2O2 at 25 °C in aqueous solution 
with 0 - 80% ACN. a - Four repeat measurements of each value were taken averaged, standard deviation 
was used as the error bar and the values fitted to the Michaelis-Menten kinetic model. Values calculated 
for kcat (b), KM (c) as well as kcat/KM (d) and total turnover numbers for 256 μM ABTS (e) were plotted 
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4.2.1.3. Michaelis-Menten Kinetics of C45 in Methanol 
The same methods were used to analyse the effects of increasing methanol 
concentration on the kinetics of C45-mediated ABTS oxidation under otherwise equal 
conditions. Results are shown in Figure 4.8. kcat values appear consistent in up to 
40% methanol, with only a 13% loss between pure buffer (0.76 s-1) and 40% methanol 
concentration (0.67 s-1). In higher cosolvent concentrations, kcat decreases rapidly. CD 
and UV-visible spectroscopy results do not indicate strong denaturation of the enzyme 
even in high methanol concentrations of 60-80%. This suggests that the decline in 
catalytic activity is either not entirely due to protein denaturation or that the 
denaturation that does occur is not observable using these spectroscopic methods.  
Total turnover numbers decrease to 32.3 ± 0.8 in 80% methanol. However, they 
are consistent in up to 60% methanol: In buffer, this is 53 ± 3, in 30-60% methanol 
between 50 and 60. In 60% methanol, the kcat decreased by 65%, however total 
turnover only declined by 5% compared to the results in pure buffer. This means each 
enzyme performs an almost equal number of substrate conversions, however at a 
much lower rate. This suggests that the lowered catalytic activity may not be primarily 
caused by enzyme denaturation. 






Figure 4.8: Michaelis-Menten kinetics of ABTS•+ formation in methanol. 
Kinetics of the oxidation of 4 - 256 μM ABTS by 100 nM C45 and 100 μM H2O2 at 25 °C in aqueous solution 
with 0 - 80% MeOH. a - Four repeat measurements of each value were taken averaged, standard 
deviation was used as the error bar and the values fitted to the Michaelis-Menten kinetic model. Values 
for kcat (b), KM (c) as well as kcat/KM (d) and total turnover numbers for 256 μM ABTS (e) were plotted 
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4.2.1.4. Michaelis-Menten Kinetics of C45 in Ethanol 
The enzyme’s catalytic behaviour in ethanol was probed using the same methods 
as in acetonitrile and methanol (Figure 4.9). The enzyme’s kcat in any ethanol 
concentration is much lower than that of C45 in pure buffer. In 10-30% ethanol, rates 
are somewhat consistent, with kcat values between 0.31 s-1 and 0.41 s-1 compared to 
0.76 s-1 in aqueous solution. In higher ethanol concentrations, kcat values decline 
steadily. In 80% ethanol no catalytic activity is observed. Total turnover numbers mirror 
this pattern. 
The lack of catalytic activity in 80% ethanol is not surprising when considering the 
denaturation observed using CD in chapter 3 (Figure 3.9). The strong decline in 
catalytic activity in lower ethanol concentrations, however, was not anticipated from 
structural analysis, similar to the decline in enzymatic activity of C45 in acetonitrile and 
methanol.  
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Figure 4.9: Michaelis-Menten kinetics of ABTS•+ formation in ethanol. 
Kinetics of the oxidation of 4 - 256 μM ABTS by 100 nM C45 and 100 μM H2O2 at 25 °C in aqueous solution 
with 0 - 80% EtOH. a - Four repeat measurements of each value were taken averaged, standard deviation 
was used as the error bar and the values fitted to the Michaelis-Menten kinetic model. Values calculated 
for kcat (b), KM (c) as well as kcat/KM (d) and total turnover numbers for 256 μM ABTS (e) were plotted 
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4.2.1.5. Michaelis-Menten Kinetics of C45 in Isopropanol 
In rising isopropanol concentrations, the decline in enzymatic activity is much 
steeper than in the other analysed cosolvents (Figure 4.10). In isopropanol 
concentrations of 30-40%, no enzymatic activity was observed. C45 was not tested in 
higher isopropanol concentrations than 40% as it is highly unlikely that the strong trend 
of decreasing catalytic activity with isopropanol addition is reversed at higher 
concentrations. 
CD results, however, only indicated denaturation in much higher isopropanol 
concentrations, above 60%. Compared to the strong decline in catalytic activity in 
much lower isopropanol concentrations, this suggests that either further unfolding 
occurred that was not observable using the spectroscopic methods employed in this 
work - such as denaturation of the tertiary structure or highly localised denaturation at 









   
 
Figure 4.10: Michaelis-Menten kinetics of ABTS•+ formation in isopropanol. 
Kinetics of the oxidation of 4 - 256 μM ABTS by 100 nM C45 and 100 μM H2O2 at 25 °C in aqueous solution 
with 0 - 40% IPA. a - Four repeat measurements of each value were taken averaged, standard deviation 
was used as the error bar and the values fitted to the Michaelis-Menten kinetic model. Values calculated 
for kcat (b), KM (c) as well as kcat/KM (d) and total turnover numbers for 256 μM ABTS (e) were plotted 
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4.2.1.6. Michaelis-Menten Kinetics of C45 in TFE 
With the increasing concentrations of acetonitrile, methanol, ethanol and 
isopropanol, the catalytic activity of C45 dropped strongly. In TFE, on the other hand, 
reaction rates and catalytic turnover of C45 actually increased (Figure 4.11).  
Due to this increase, a wider range of substrate concentrations was used (2 – 
1024 μM ABTS) to obtain more accurate data. However, the values for 
𝑣0
[𝐸]0
  reached a 
plateau at ABTS concentrations above approximately 150 μM and did not increase 
significantly with higher substrate concentrations. 
Furthermore, to ensure consistency of these results, the experiment in 80% TFE 
was conducted four times and results averaged. Due to the large increase in reaction 
rate and the associated strong absorbance, measurements were performed with a 
lower C45 concentration, which was accounted for in calculations of kinetic 
parameters. 
In up to 30% TFE, kcat remains at a consistent level, however, in 50-60% TFE, kcat 
is approximately 60% higher than in aqueous solution, at 1.22 s-1 ± 0.08. This rises 
further to 2.2 s-1 ± 0.3 in 60% TFE. In 80% TFE, the highest cosolvent concentration 
tested, kcat is 5.1 s-1 ± 0.3, a 7-fold increase to the kcat in aqueous solution.  
The total turnover number was plotted for both 256 μM, as in the previous 
experiments, and 1024 μM, the maximum ABTS concentration used in TFE. 
Interestingly, the two data sets overlap strongly, suggesting that no further increase in 
total turnover number occurs at substrate concentrations above 256 μM. This implies 
that at 256 μM ABTS, the reaction is sufficiently saturated for maximum total turnover.  







Figure 4.11: Michaelis-Menten kinetics of ABTS•+ formation in TFE.  
Kinetics of the oxidation of 2 - 256 μM ABTS by 10, 25 and 50 nM C45 and 100 μM H2O2 at 25 °C in 
aqueous solution with 0 - 80% TFE. a - Four repeat measurements of each value were taken averaged, 
standard deviation was used as the error bar and the values fitted to the Michaelis-Menten kinetic model. 
For clarity, measurements at 512 and 1024 μM ABTS are not shown.  
Values calculated for kcat (b), KM (c) as well as kcat/KM (d) and total turnover numbers for 256 μM and 1024 
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Whilst both total turnover number and kcat increase with ascending TFE 
concentrations, the total turnover does this at a much steeper rate, as shown in Figure 
4.12. The rising total turnover number indicates that each enzyme molecule performs 
a much larger number of conversions in 80% TFE than in aqueous solution. The rate 
at which these conversions occur is also much higher but does not increase by the 
same factor. There might be some stabilisation of an intermediate, possibly compound 
I, which positively impacts both kcat and total turnover number.  
 
 
Figure 4.12: kcat and total turnover number (TTN) in TFE. 
a – TTN plotted against kcat, showing both increase significantly in rising TFE concentrations. b – Ratios of 
kcat and TTN in TFE to the same values in buffer, showing that the TTN increases at a much steeper rate 
than the kcat as TFE concentration is raised. 
 
4.3. Discussion 
In this chapter, the impact of different cosolvents on the peroxidase activity of C45 
was scrutinised. In buffer, this reaction proceeds with a kcat of 0.76 s-1 ± 0.07 under 
limiting concentrations of peroxide (100 μM). Under these conditions and 256 μM 








determined for C45. The KM of this reaction could not be adequately calculated as this 
requires accurate data for the reaction rate at low substrate concentrations. At low 
substrate concentrations, the activities are challenging to measure due to the reactive 
nature of intermediate compound I and more accurate data would require several 
replicates. Similarly, the total turnover number showed a strong dependency on the 
concentration of ABTS which is most likely also due to the reactivity of compound I. 
In the organic cosolvents tested, with the exception of TFE, kcat and total turnover 
number generally decreased with increasing cosolvent concentrations (Figure 4.13). 
As indicated in Table 4.2, cosolvent concentrations of 30% or lower already affected 
the peroxidase activity of C45. Excitingly though, in TFE, the highest cosolvent 
concentration of 80% yielded the greatest kcat of 5.1 s-1 ± 0.3 and total turnover number 
of 1840 ± 140. 
Table 4.2: Highest kcat values for ABTS oxidation in different cosolvents. 
 [Cosolvent] kcat (s
-1) 
Buffer   0.76 ± 0.07 
ACN 20% 0.72 ± 0.03  
MeOH 30% 0.75 ± 0.06 
EtOH 20% 0.41 ± 0.03 
IPA 10% 0.44 ± 0.03 
TFE 80% 5.1 ± 0.3 
 
Literature (3, 5, 139, 145, 287) as well as structural data presented in chapter 3 
suggested that helical proteins such as C45 might be more stable in TFE. From this, 
an increase in enzymatic activity, manifested in a higher kcat and total turnover number, 
could be expected. This was indeed the case, the catalytic activity of C45 increased 
strongly in TFE, however significantly more so than anticipated from the observed 
structural changes. This was particularly notable in high concentrations of TFE: In 80% 
cosolvent concentration, the kcat measured was 5.1 s-1 ± 0.3, a 7-fold increase on the 
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kcat in aqueous solution. The total turnover number, however, increased by a much 
larger factor. At 1840 ± 140, this is approximately 34 times larger than the total turnover 
number in water (both calculated at an ABTS concentration of 256 μM). In other 
cosolvents, the relative change in kcat and total turnover number are much more 
parallel. Generally, compared to the change observed in both kcat and total turnover 
number in TFE, the change of catalytic activity in other cosolvents is small. This 
suggests that the intermediates in the reaction, especially the highly reactive radical 
compound I, are stabilised by TFE and the desired reaction with the substrate is 
favoured strongly over side reactions that would result in enzyme degradation.  
 
Figure 4.13: Total turnover number and kcat for different cosolvents. 
A decrease of catalytic activity can be seen as cosolvent concentration is increased for all cosolvents, 




In other cosolvents, the general trend appeared to be an inverse relationship of 
cosolvent concentration and catalytic activity, which is common for enzymology in 
aqueous organic mixtures (13, 16). kcat values in methanol and acetonitrile are very 
similar to each other, exhibiting resilience to cosolvent concentration of up to 40% 
before steadily decreasing with rising cosolvent concentration. In ethanol, kcat values 
drop more precipitously as cosolvent concentration is elevated than in methanol or 
acetonitrile, and in isopropanol even more so, with total turnover numbers also 
reflecting this decline in enzymatic activity. To determine whether this is a generic 
trend of decreasing catalytic activity in alcohols of increasing carbon chain length, 
further analysis would be required. This observed behaviour may also be related to 
polarity – in particular, polarity as measured by the ET(30) scale (Table 3.1) - as less 
polar cosolvents tended to produce a greater decline in enzymatic activity, which may 
be indicative of some interference substrate-binding. The binding of organic substrates 
is often driven by hydrophobic interactions which may be disrupted by a less polar 
solvent. Again, this theory would require further testing with a wider range of 
cosolvents. 
The general trend of decreasing catalytic activity with increasing organic cosolvent 
concentration is coherent with the loss of structure in high cosolvent concentrations 
that was demonstrated in chapter 3. However, the spectroscopic data presented in 
chapter 3 only indicate loss of structure in cosolvent concentrations of 60% or higher. 
The decline of enzymatic activity, however, commences at much lower cosolvent 
concentrations. This suggests one of two possibilities. Either this decline in enzymatic 
activity is not primarily caused by denaturation of the protein or there is more unfolding 
occurring than observable using CD and UV-visible spectroscopy. This could, for 
instance, be highly localised denaturation capable of deactivating the protein without 
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effecting sufficient loss of topology for these methods to expose. It may be worth 
analysing the protein structure in cosolvents using some different methods, such as 
NMR.  
Generally, the negative impact of cosolvents on the function of C45 is not 
unanticipated, however the behaviour of C45 in TFE is intriguing. The difference in the 
impact of TFE and other cosolvent seems to be two-fold: Firstly, the increase rather 
than decline in enzymatic activity with the addition of TFE and secondly the possible 
stabilisation of intermediates. To gain further insights into the complete kinetics of C45 
in TFE, especially at the initial stages of the reaction, and to understand the underlying 
mechanisms, this was probed further. A more thorough investigation of the catalytic 


















5. Further kinetic and structural 
analysis of C45 in TFE 
 
In the previous chapters, the secondary structure and catalytic activity of C45 was 
studied in buffer, acetonitrile, methanol, ethanol, isopropanol and TFE. While 
secondary structure appeared to be resilient to the addition of up to 80% cosolvent 
and even increases in helicity with the addition of alcohols, catalytic activity generally 
declined significantly after the addition of 50% cosolvent. The exception was TFE, 
which significantly enhanced catalytic activity, especially at 80% cosolvent 
concentration. In this chapter, the peroxidase kinetics of C45 in buffer and 80% TFE 
are thus probed more thoroughly and steady-state as well as pre-steady-state kinetic 
data presented. Furthermore, a comparison with horseradish peroxidase is performed, 
as well as an investigation into the mechanism of compound I formation. Finally, the 
structural effects of TFE on C45 were probed using analytical SEC, SEC-SAXS and 
NMR. 
5.1. Introduction 
TFE is a water-miscible, amphiphilic alcohol that can stabilise both the polar 
exterior and the hydrophobic core of a protein. Mixtures of water and TFE have been 
shown to stabilise secondary structural motifs in proteins, in particular α-helices (3, 4, 
139). The mechanism for this is not fully understood yet, however, displacement of the 
aqueous hydration shell with TFE likely leads to destabilisation of random coils and 




such stabilisation (3, 5, 139, 145). Nonetheless, these effects primarily act on short 
range interactions, and have been shown to actually destabilise protein tertiary 
structure in order to increase the protein helical content in some instances (141, 142). 
This is unlikely in C45 though, as the protein comprises only helices and short loops 
of serine and glycine, which have been demonstrated to function as α-helix caps even 
in TFE (3). The observed increases in helicity in C45 are therefore more likely a result 
of a higher stability of the helical fold over random coil. Many enzymes, including 
horseradish peroxidase, exhibit a strong decline in catalytic activity upon the addition 
of over 30% TFE (6, 288–290), even if in some instances lower concentrations yielded 
a slight increase in catalytic activity. Therefore, the significant rise in enzymatic activity 
of C45 in a TFE concentration as high as 80% was surprising, sparking interest in a 
more thorough comparison of the kinetics of C45 in aqueous solution and 80% TFE.  
Kinetic isotope effects may provide valuable insights into the kinetics and 
mechanism of a reaction (291), and are determined by the reaction rate ratios with a 
light and a heavy isotope. While this effect can be seen between isotopes of any 
element, the relative change in nuclear mass – and therefore the difference in zero-
point energy which is inversely related to nuclear mass – is largest between hydrogen 
and deuterium (292). A deuterium bond has thus a the lower zero-point energy than a 
hydrogen bond, meaning that more energy is required to break a deuterium bond than 
a corresponding bond involving hydrogen (293). Figure 5.1 shows a Morse potential 
energy curve of bonds between carbon and the two hydrogen isotopes. The diagram 
especially highlights the relation between zero-point energy of a bond and its 
dissociation energy.  




Figure 5.1: A Morse potential energy curve of C-H and C-D bonds. 
 
This means that a reaction step where carbon-hydrogen bonds are broken can be 
measurably slowed down by substituting the hydrogen atom with its heavier isotope. 
This difference in reaction rate is known as the kinetic isotope effect (KIE) and can be 
described by the following ratio of rate constants. 







  Kinetics of C45 with high substrate concentration 
As previously discussed, the reaction between C45 consumes hydrogen peroxide 
and ABTS to form the turquoise radical cation ABTS•+, following ping-pong kinetics. In 
chapter 4, this reaction was performed in various cosolvents under limiting peroxide 
concentrations. A more complete analysis of this reaction – with the concentrations of 
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both substrates varied and performed on a stopped-flow spectrometer – has been 
conducted in buffer and 80% TFE. This instrument can investigate much faster 
reactions and allowed the usage of higher substrate concentrations (0.1-3 mM ABTS 
and 5-200 mM H2O2). Twelve replicates were measured for each data point in two 
separate experiments and results averaged (Figure 5.2). 
 
 
Figure 5.2: Kinetics of ABTS and peroxide turnover by C45 in buffer and 80% TFE. 
Data for ABTS oxidation by C45 in buffer (a) and 80% TFE (b) are fitted to a ping-pong kinetic model. 
 
The data obtained for C45 in buffer were fitted to the ping-pong model, with fits 
suggesting a kcat of 890 ± 60 s-1, a KM  for H2O2 of 220 ± 30 mM, a KM  for ABTS of 
0.70 ± 0.04 mM and a kcat/KMa/KMb of 5.8 × 106 M-1 M-1 s-1. It is, however, noteworthy 
that especially in higher ABTS concentrations (1 mM and above), the fits matched the 
experimental data very poorly and the errors associated with the data calculated from 
these fits are therefore likely larger. 
The calculated kcat of 890 s-1 was significantly smaller than the previously 
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the same buffer and at the same temperature and pH, but with different C45 
concentrations (2). As batch to batch variation was minimal (see section 7.1 in the 
Appendix), the impact of enzyme concentration on the reaction is investigated in the 
following section. 
Further, the data for the reaction in 80% TFE confirm that the presence of this 
cosolvent significantly increases the reaction rate to the extent that saturation was not 
achieved with the substrate concentrations used. Because of this, an accurate fit and 
calculations for a KM for H2O2 and a kcat could be performed. 
In contrast to the kcat and the KM for H2O2, the KM for ABTS could be fitted, and 
was calculated to be 2.8 ± 0.05 mM. From the slope, the kcat/KMa/KMb was estimated 
to be 2.1 × 107 M-1 M-1 s-1 which is a 4-fold increase on the catalytic efficiency in buffer. 
Neither kcat nor KM for H2O2 could be determined with the substrate concentrations 
used here, however. The kinetic parameters determined both in buffer and 80% TFE 
are summarised in Table 5.1. 
Table 5.1: Kinetic parameters for ABTS and peroxide turnover by C45 in buffer and 80% TFE. 
 
 
  kcat (s-1) 
KM for H2O2 
(mM) 
KM for ABTS 
(mM) 
 kcat/KMa/KMb 
(M-1 M-1 s-1) 
Buffer 890 ± 60 220 ± 30 0.70 ± 0.04 5.8 × 106 
80% TFE - - 2.8 ± 0.05 2.1 × 107 
 
5.2.1.1. Impact of C45 concentration 
In light of the discrepancy between kinetic results obtained consistently within this 
work and those in the literature in the same buffer and at the same temperature and 
pH, but with different C45 concentrations, the impact of the enzyme concentration was 
investigated. C45 concentration was thus varied, with two sets of substrate of high (3 
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mM ABTS and 200 mM H2O2) and low (0.1 mM ABTS, 25 mM H2O2) concentrations 
(Figure 5.3).  
Surprisingly, the enzyme concentration significantly influenced v0/[E]0. Rate 
increases are generally proportional to enzyme concentration and the initial rate 
normalised for enzyme concentration should be constant for all enzyme 
concentrations. For C45, however, this increases significantly with increasing enzyme 
concentration, regardless of substrate concentration and reaction medium (aqueous 
buffer or 80% TFE).  
 
 
Figure 5.3: Enzyme concentration dependent v0/[E]0 for the reaction between C45, ABTS and H2O2 in 
buffer (a) and 80% TFE (b). 
 
This is likely to be caused by oligomerisation. Chromatography results (see Figure 3.3 
as well as SEC-SAXS and analytical SEC results presented in sections 5.2.6 and 
5.2.7) show that C45 exists as a mixture of dimer and monomer. It is possible that the 
dimer has a higher catalytic activity than the monomer. As a higher proportion of dimer 
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 Mechanism of compound I formation1 
To better understand the mechanism of ABTS and peroxide turnover by C45 and 
the rate enhancing effect of TFE, the formation of compound I was investigated in both 
buffer and 80% TFE. According to the hypothesised reaction scheme for the oxidation 
of ABTS by C45 (Figure 4.1), the first step in this reaction is peroxide binding, followed 
by proton shuffling and elimination of water (Figure 5.4). 
Figure 5.4: Proposed mechanism of compound I formation from C45 and hydrogen peroxide. 
The reaction between 1 μM C45 and 10-50 μM peroxide was probed by stopped-
flow to determine the rate-limiting step of the reaction – proton shuffling or water 
elimination. Reactions were performed with hydrogen peroxide in buffer with and 
without 80% D2O (Figure 5.5). In addition, the effect of 80% TFE in non-deuterated 
buffer was probed to test the impact of the cosolvent on the reaction. In order to slow 
down the reaction sufficiently to observe compound I formation, kinetic assays were 
performed at 5 °C, and a dead time of 1 second was used to allow for an adequately 
long mixing period. Double-exponential kinetics with rates k1 and k2 were observed for 
the reaction in buffer and 80% D2O, whereas the reaction in TFE followed triple-
exponential kinetics. 
1 In collaboration with Dr Adrian Bunzel (University of Bristol, School of Biochemistry). 




      
       
  
Figure 5.5: Kinetics of compound I formation. 
a-d -Experimental measurement of absorbance at 403 nm over time for the reaction between 1 μM C45 
and (a) 50 μM H2O2 in buffer, (b) 50 μM D2O2 in buffer, (c) 50 μM H2O2 in 80% TFE (d) 0 μM H2O2. In 80% 
TFE – this is an artefact attributed to the mixing of TFE and water and the accompanying rupture and 
formation of micelles. 
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In the case of TFE, the additional exponential was also observed without the 
addition of peroxide. This process with the rate kbg is likely a background artefact of 
TFE related to the rupture and reformation of micelles during mixing. 
Since the reactions were monitored using a photodiode array, the data were 
globally fitted for all wavelengths between 350 nm and 600 nm with shared rate 
constants. For the reaction in buffer and 80% D2O, a double exponential was used for 
fitting:  
  𝐴 =  𝐴1𝑒
−𝑘1𝑡 + 𝐴2𝑒
−𝑘2𝑡 + 𝐶 5.2 
 
In contrast, the data in 80% TFE were fitted to a triple exponential: 
  𝐴 =  𝐴1𝑒
−𝑘1𝑡 + 𝐴2𝑒
−𝑘2𝑡 + 𝐴𝑏𝑔𝑒
−𝑘𝑏𝑔𝑡 + 𝐶 5.3 
 
with kbg being held constant to its previously determined value from fitting the mixing 
data (0.26 ± 0.02 s-1) without peroxide to a single exponential:  
  𝐴 =  𝐴𝑏𝑔𝑒
−𝑘𝑏𝑔𝑡 + 𝐶 5.4 
 
Importantly, in buffer and 80% D2O, no additional background phase was observed. 
The first process thus likely corresponds to compound I formation, and the second 
process possibly a variety of processes including solvent interactions and 
decomposition of compound I. Figure 5.6 shows the two rate constants k1 and k2 for 
all three experiments. 
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Figure 5.6: Peroxide concentration dependent rate constants for ABTS oxidation by C45 at 5 °C. 
a – k1, which has been assigned to compound I formation. b – k2 which likely includes the degradation of 
compound I. 
There is a clear trend for the rate to decrease when hydrogen peroxide is 
substituted with D2O2. The kinetic isotope effect was calculated at the maximum 
peroxide concentration of 50 μM, as this is associated with the lowest error. Values for 
the kinetic isotope effect for both rate constants are shown in Figure 5.7. For the first 
rate constant k1, this is greater than 2, whereas for the second rate constant k2, it is 
not significantly greater than 1.  
Figure 5.7: Deuterium substitution kinetic isotope effects for k1 (KIE1) and k2 (KIE 2). 
ba
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The kinetic isotope effect on k1 indicates that this process involves the partially 
rate-limiting cleavage of a proton-bond prior to compound I formation. This observation 
corroborates the hypothesis that proton-shuffling prior to compound I formation is rate 
limiting in C45. This is in line with the elevated KM for H2O2, and the absence of proton-
shuffling bases such as a distal histidine often present in natural analogues (294).  
The half-life t1/2 of the formation of compound I (determined from the rate constant 






Unpublished data from electron paramagnetic resonance spectroscopy suggest 
that at 25 °C, C45 has a half-life of 1-2 seconds for compound I formation, and its 
decomposition has a half-life of 10-100 seconds, which fits well with this data as 
temperature has a strong effect on reaction rate. 
Notably, a linear fit of k1 versus peroxide concentration indicates a non-zero rate 
at 0 μM peroxide. This may be suggestive of a significant k-1 corresponding to the 
unbinding of peroxide. Along with the very high KM values for hydrogen peroxide, this 
most likely indicates that C45 has only limited H2O2 affinity. 
In terms of TFE, it was observed that k1 and k2 were significantly faster in 80% 
TFE, especially at the more accurately determined higher concentrations of peroxide. 
This supports the previous observation that activity is drastically increased in TFE, and 
suggests that this is due to a significant increase in k1, the rate of compound I 
formation. This is not only shown by the significantly higher k1, but also by the clear 
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positive slope observed for the linear fit of k1 versus peroxide concentration. This 
slope, corresponding to kobs = 25.9 +- 0.7 M-1s-1, is close to zero without TFE and 
indicates that turnover of peroxide is more efficient. 
  Steady-state kinetics of Horseradish Peroxidase with low 
substrate concentrations 
In order to put the kinetic activity of C45 into perspective, it was compared to 
horseradish peroxidase (HRP) which has been subject to scientific investigation for 
over two centuries and is very well characterised (177). Steady-state kinetics were 
performed to analyse the HRP-mediated oxidation of ABTS to ABTS•+ in the presence 
of hydrogen peroxide in buffer and 80% TFE. The conditions chosen were similar to 
those previously used to measure activity under limiting peroxide concentrations: 25 
°C, 100 μM H2O2 and redox buffer (20 mM CHES, 100 mM KCl, pH 8.6). The 
concentration of HRP used was 15-108 nM in buffer and 15-60 nM in 80% TFE.  
The results (Figure 5.8) show that horseradish peroxidase is significantly more 
active in buffer than C45, with kcat and total turnover number under limiting peroxide 
concentrations increasing 100-fold and 10-fold, respectively. Upon addition of 80% 
TFE, however, HRP is almost entirely deactivated and loses ≥99% in kcat, from 95 s-1 
to 0.066 s-1. This stands in stark contrast to the 7-fold enhancement in kcat exhibited 
by C45 when the aqueous reaction medium is replaced with 80% TFE. Table 5.2 
summarises the observed kinetic parameters for the reactions of C45 in buffer and 
80% TFE. This is in agreement with the literature which states that high TFE 
concentration inactivates horseradish peroxidase (6).  
It is not clear exactly what causes this difference in behaviour upon exposure to 
high TFE concentrations. However, a strongly contributing factor may be the excessive 
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stabilisation of helices over the native tertiary structure which has previously been 
observed in other enzymes (141). The native conformation of C45 is mostly helical, 
with connecting loops of serine and glycine, which will terminate the propagation of 
helices even in TFE (3). Horseradish peroxidase, in contrast, contains some β-sheets 
and more random coil. It is possible that the enzyme’s native conformation, which 
supports its enzymatic function, becomes excessively helical at the cost of catalytic 
activity. CD could be employed to investigate this further. 
Less likely is a loss of conformational flexibility associated with the addition of the 
TFE, which has been shown to rigidify proteins (3). This may interfere with the ability 
of horseradish peroxidase to bind substrates, as conformational fluctuations are 
important for accessibility of the active site to peroxide (295). In horseradish 
peroxidase, which is approximately thrice the size of C45, the active site is buried on 
the inside and accessible via a bottleneck entry (296). Therefore, if TFE reduces 
mobility of horseradish peroxidase, this would be detrimental to the enzyme’s catalytic 
activity, an effect that would be less likely in C45. 
5.2. Results – Steady-state kinetics of Horseradish Peroxidase 
150 
Figure 5.8: Kinetics of ABTS oxidation by HRP and C45 in the absence and presence of TFE. 
a – Horseradish peroxidase, 100 μM H2O2 and varying ABTS in buffer (20 mM CHES, 100 mM KCl, pH 8.6). 
b - Horseradish peroxidase, 100 μM H2O2 and varying ABTS in 80% TFE. c – Comparison of horseradish 
peroxidase and C45 with 100 μM H2O2 and varying ABTS in buffer and 80% TFE. 
Table 5.2: Kinetic parameters of ABTS oxidation by C45 and horseradish peroxidase (HRP) in buffer and 
80% TFE. 
kcat (s-1) KM (μM) kcat/KM (s-1 μM-1) 
TTN 
C45 Buffer 0.76 ± 0.7 24 ± 7 0.033 ± 0.008 53 ± 3 
C45 80% TFE 5.1 ± 0.3 10 ± 4 0.5 ± 0.2 1800 ± 200 
HRP Buffer 95 ± 4 8400 ± 700 0.011 ± 0.001 606 ± 4 
HRP 80% TFE 0.066 ± 0.006 50 ± 20 0.0013 ± 0.0005 29 ± 3 
a b
c
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 Metallocarbenoid formation by C452 
It has recently been demonstrated that C45 is a very versatile enzyme, with not 
just peroxidase functionality, but also the ability to act as a carbene transferase (220). 
A preliminary experiment was performed to confirm whether the formation of a 
metallocarbenoid (Figure 5.9) also proceeds in high TFE concentrations (75%). The 
reaction between C45 (reduced by sodium dithionite, Na2S2O4) and ethyl diazoacetate 
(EDA, C4H6N2O2) was monitored under anaerobic conditions (Figure 5.10). 
Figure 5.9: Mechanism of metallocarbenoid formation by reduced C45 (symbolised as FeII).  
Figure supplied by Richard Stenner. 
Figure 5.10: Kinetics of C45 mediated metallocarbenoid formation at increasing EDA concentration in 
75% TFE. 
2 Performed in collaboration with Richard Stenner (University of Bristol, School of Biochemistry). 
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The observed limiting rate constant klim of this reaction is 0.71 ±0.04 s-1, with a 
pseudo-Michaelis constant K1 of 180 ± 40 μM. The efficiency (klim/K1) is thus 0.004 ± 
0.002 s-1 μM-1. In buffer, the values measured were klim = 0.5 s-1, K1 = 74 and klim/K1 
=0.007. 
While this is a preliminary result that would require repeats to yield reliable results, 
it does suggest that TFE neither strongly improves metallocarbenoid formation nor 
does it hinder it. This is very different from the 7-fold rate enhancement that the 
cosolvent had on ABTS oxidation. These strongly different effects of TFE on reaction 
kinetics suggest that the cosolvent has a stabilising effect on compound I in the 
peroxidase reaction and the enhancement of peroxidase catalysis is not caused by 
the generic stabilisation of the enzyme. 
 Nuclear Magnetic Resonance (NMR) spectroscopy of C453 
To observe the effect of TFE on the protein further, NMR spectroscopy of C45 in 
buffer and in 80% TFE was performed. The 1H NMR spectra (Figure 5.11) of C45 in 
buffer and 80% TFE are very comparable, suggesting the protein is not chemically 
denatured with the addition of TFE. The regions that the peaks are attributed to are 
highlighted in green. The spectrum in 80% TFE is, however, slightly better resolved, 
suggesting increased stability of the protein. 
3 In collaboration with Dr Adrian Bunzel (University of Bristol, School of Biochemistry) and Dr Chris 
Williams (University of Bristol, School of Chemistry) 




Figure 5.11: 1H NMR spectrum of C45 in buffer (red) and 80% TFE (blue).  
The peak at 3.5 ppm is attributed to CHES present in the buffer.  
 
For better resolution, 2D-NMR spectra were obtained (Figure 5.12). Generally, the 
spectra in buffer and 80% TFE appear to show the same peaks: peaks in the region 
characteristic for random coil serine and glycine can be identified, which correspond 
to the loop regions of the protein (2). Further, the peaks highlighted in green circles 
likely correspond to the amide groups in the side chains of glutamine and asparagine 
(297–299). The similarity of the spectra in buffer and 80% TFE is a good indicator that 
the protein structure is not significantly altered by the cosolvent. Nonetheless, signals 
observed for C45 in 80% TFE are slightly improved, which may indicate increased 
stability and rigidity of the protein which is in good agreement with the literature (3). 
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Other potential explanations for this result could be a lesser degree of self-association 
of the protein or reduced viscosity of the solution with 80% TFE. SOFAST-HMQC 
spectra had been obtained for C45 in buffer previously (2), with very comparable 
results, whereas TROSY-HSQC spectra were chosen as a complementary analysis 
exhibiting better resolution in different regions. Both types of 2D-spectra as well as the 
1D 1H spectrum suggest that the addition of TFE has a beneficial effect on the 
structural stability of the protein. 
 
Figure 5.12: 2D NMR spectra of C45 in aqueous solution and 80% TFE. 
1H -15N SOFAST HMQC of C45 in buffer (a) and 80% TFE (b) and 1H -15N TROSY-HSQC spectra in buffer (c) 
and 80% TFE (d). 
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 Small Angle X-ray Scattering of C454 
In order to analyse the oligomerisation status of C45 both in buffer and in 80% 
TFE, the protein was subjected to size exclusion chromatography coupled Small Angle 
X-ray Scattering (SEC-SAXS). A sample of 1 mM C45 in buffer (20 mM CHES, 100
mM KCl, pH 8.6) was injected into an analytical size exclusion column and eluted in a 
double peak (Figure 5.13).  
Figure 5.13: SEC-SAXS chromatogram of C45 in buffer. 
Absorbance of the eluting solution at 280 nm (orange) overlaid with radius of gyration (blue) for the whole 
chromatogram (a) and a closer view of the elution peak of C45 (b).  
4 In collaboration with Dr Adrian Bunzel (University of Bristol, School of Biochemistry). 
b
a
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While the peaks are poorly resolved, SAXS analysis of the eluting solution 
confirmed the presence of two species.  
Scattering is presented as q, known as the scattering vector or momentum 
transfer, which can be calculated from the scattering angle (2θ) and beam wavelength 
λ using the following equation: 
 𝑞 =  
4𝜋 𝑠𝑖𝑛 𝜃
𝜆
  5.6 
 
The scattering vector and intensity I could be used to calculate a P(r) distribution 
which describes the distance between a pair of points within a scattering particle (237, 
300).  











It can provide some information about shape of a particle as well as its radius of 
gyration (Rg). This parameter is a measure of particle size that is calculated as 
according to the following equation 5.8: 
 𝑅𝑔









Dmax is the maximum dimension of the particle. 
ScÅtter software was used to fit a p(r) distribution from the raw data and calculate 
radius of gyration Rg maximum dimension Dmax. Furthermore, the Porod volume VP 
was calculated by the programme. 
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Where I0 is the intensity in line with the beam and Q is the Porod invariant which is 
related to the surface to volume ratio of particles (301). 
 
  








K4 is a constant which ensures proportionality between asymptotical intensity 
decay and q-4 at higher angles.  
These calculations were performed computationally using the ATSAS programme 
(240, 241). Scattering curves as well as the distribution functions p(r) for the two eluting 
peaks in buffer are shown in Figure 5.14. 
The two species (eluting at approximately 290 ml and 325 ml) were calculated to 
have radii of gyration of 36 and 23 Å, respectively, with Porod volumes of 85,000 and 
40,000 Å3, respectively. This corresponds roughly to a size ratio of 2:1, confirming the 
presence of a dimer and monomer. Furthermore, the shape of the curve suggests that 
the monomer is rod-shaped. The dimer is likely also somewhat oblong, but less 
cylindrical than the monomer. Figure 5.15 shows the shapes density distribution 
function graphs typically adopt for differently shaped particle in small-angle scattering. 
 




Figure 5.14: SAXS scattering curves and P(r) distributions for C45 in buffer. 
a, c – scattering curves of the solution eluting between 288-298 and 320-330 ml respectively. Light red 
dots show data points and the red line is the best fit line. b, d – P(r) distributions of those species. 
 
 
Figure 5.15: Typical shapes of density distribution functions for different particle sizes.  
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Scattering profiles were fitted to produce 3-dimensional models using SASREF 
and DAMMIF software by EMBL Hamburg (242). Three-dimensional models (Figure 
5.16) suggest more complex shapes than predicted by the P(r) distribution. Both 
resemble a slightly elongated cylinder with a small adjoined lobe, although of course 
the dimer is larger in size and more rod-like. The computationally produced model of 
C45 is shown for scale and comparison, it is notably more elongated and significantly 
smaller. This suggests that the protein might fold less tightly than expected, but also 
casts doubt on the accuracy of the SAXS models and highlights the importance of 
repeat experiments. 
Figure 5.16: 3D models of C45 in buffer produced from scattering profiles. 
Models of the predicted protein structure (2) shown for comparison. 
a– suspected dimer (eluting at 288-298 ml) resolved to 40 Å. b- suspected monomer (eluting at 320-330 
ml) resolved to 31 Å.
a
b
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C45 in 80% TFE (at a concentration of 0.7 mM) was also subjected to SEC-SAXS 
and eluted as two species, poorly separated by chromatography (Figure 5.17).  
 
 
Figure 5.17: SEC-SAXS chromatogram of C45 in 80% TFE. 
Absorbance of the eluting solution measured at 280 nm (orange) overlaid with radius of gyration (blue) 
for the whole chromatogram (a), including elution of TFE and re-equilibration of the column into buffer 
as seen at around 550 ml, and a closer view of the elution peak of C45 (b).  
 
The two species eluting at approximately 295 ml and 325 ml were predicted to 
have a volume of 87,000 and 34,000 Å3, respectively, and a radius of gyration of 38 
and 25 Å. The Dmax values were determined as 119 and 93 Å, respectively. The 
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to those of C45 in buffer, suggesting that the species present here are also dimer and 
monomer. Scattering curves and density distribution functions for the two species of 
C45 in 80% TFE are presented in Figure 5.18. 
Figure 5.18: SAXS scattering curves and P(r) distributions for C45 in 80% TFE. 
a, c – scattering curves of the solution eluting between 291-296 and 319-328 ml respectively. Light blue 
dots show data points and the blue line is the best fit line. b, d – P(r) distributions of those species. 
The shapes of the density distributions are comparable to those observed of C45 
in buffer, suggesting that like in buffer, in 80% TFE the C45 monomer is rod-shaped 
whereas the dimer is elongated, but not perfectly cylindrical. In the 3-dimensional 
models (Figure 5.19), the monomer appears to have a similar shape as in buffer, with 
the dimer being less elongated than in buffer. Both monomer and dimer appear to 
resemble a molten globule rather than rod-shaped protein. As with the models in 
a b
c d
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buffer, PyMol models are shown alongside for comparison, and similarly, both shape 
and size differ between computationally predicted structure and SAXS 3D models. To 
ensure accuracy of the SAXS models, further experiments would be required, ideally 
including x-ray crystallography. 
Figure 5.19: 3D models of C45 in 80% TFE produced from scattering profiles. 
Models of the predicted protein structure (2) shown for comparison. 
a– suspected dimer (eluting at 291-296 ml) resolved to 62 Å. b- suspected monomer (eluting at 319-328 
ml) resolved to 32 Å.
The bell-shaped normalised Kratky plots (Figure 5.20) indicate that both monomer 
and dimer are folded in both environments (buffer and 80% TFE) (303). 
a
b
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Figure 5.20: Normalised Kratky plots for C45 in buffer and 80% TFE. 
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A summary of the calculated parameters of the species present in C45 solutions 
in buffer and 80% TFE is provided in Table 5.3. It shows that in buffer and in 80% 
TFE, two species elute, which are most likely a monomer and a dimer in each solution. 
This suggests that in 80% TFE, the quarternary structure of C45 is not significantly 
affected by the cosolvent at the timescales and concentrations analysed. It is, 
nonetheless, possible that over prolonged incubation times, the cosolvent stabilises 
the dimer over the monomer or vice versa. 




(ml)  VP (Å3) Dmax (Å) Rg (Å) Χ2 
Buffer 288-298 85000 113 36 0.27 
Buffer 320-330 40000 89 23 0.14 
80%TFE 291-296 87000 119 38 0.19 
80% TFE 319-328 34000 93 25 0.57 
 
  Analytical Size Exclusion Chromatography of C45 
In order to analyse the behaviour of the monomer and dimer of C45 in buffer and 
in 80% TFE over prolonged periods of incubation, the protein was subjected to 
analytical size exclusion chromatography, with absorbance monitored at both 280 nm 
and 405 nm. A poorly resolved double peak eluted that was split into two fractions 
(Figure 5.21 a).  
This was suspected to be C45 in dimeric and monomeric form. Absorbance at 405 
nm was more intense, but absorbance at 280 nm was better resolved, so the latter 
was used to separate between the two peaks. Fractions were acquired of the shoulder 
regions of each peak to limit crossover. Immediately after elution, the collected 
fractions were diluted to a concentration of 2 μM in buffer and 80% TFE and analysed 
using size exclusion chromatography once more (Figure 5.21 b). This analysis was 
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repeated for each of the four samples at 12, 24, 48 and 72 hours after elution and 
separation (Figure 5.22).  
Figure 5.21: Analytical size exclusion chromatogram of C45. 
a - A poorly resolved double peak elutes, with two fractions obtained (red shows the suspected dimer and 
blue the suspected monomer). b – Chromatogram of fractions from (a) diluted to 2 μM in buffer or 80% 
TFE subjected to further SEC. 
The subsequent chromatograms of the second fraction in both buffer and 80% 
TFE all exhibited a single peak with comparable intensity, indicating that the monomer 
is stable at room temperature in these conditions and does not spontaneously 
dimerise. The other fraction obtained, which was suspected to be dimeric C45, 
produced two peaks on subsequent chromatograms, suggesting the presence of 
dimer and monomer. While some of that is likely owed to the poor resolution of dimer 
and monomer in the initial experiment (Figure 5.21 a), further analysis of the two 
peaks showed the ratio of them to be changing with incubation time. 
a b
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Figure 5.22: Analytical size exclusion chromatograms for C45 in buffer and 80% TFE. 
a, b – Suspected dimer (fraction from peak 1 from initial analytical SEC) in buffer (a) and 80% TFE (b) at 0-
72 hours after elution. c, d - Suspected monomer (fraction from peak 2 from initial analytical SEC) in buffer 
(c) and 80% TFE (d) at 0-72 hours after elution.
Absorbance was measured at 405 nm and 280 nm; however, spectra are only shown for 405 nm where
absorbance was stronger.
For each subsequent run of the dimer fraction, the two maxima were calculated 
both at 280 nm and 405 nm and the minimum absorbance at the start of the run 
subtracted. Due to the high levels of noise, averages of at least six data points were 
taken for determination of maximum and minimum absorbance. The ratio of dimer 
peak to monomer peak decreases with incubation time, suggesting the dimer 
dissociates into monomers (Figure 5.23). This proportional decrease in dimeric C45 
a b
c d
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is consistent between buffer and 80% TFE, suggesting the monomeric form is 
favourable at this protein concentration in both solutions. However, data were very 
noisy and the experiment would require repeats conducted with varying protein 
concentrations before being viewed as any more than a qualitative, preliminary result. 
Figure 5.23: Ratio of first eluting peak to second eluting peak for C45 in buffer (red) and 80% TFE (blue).  
Additionally, a single kinetic measurement of both the dimer and monomer was 
performed immediately after separation of the two fractions (Figure 5.24). The 
reaction between 500 nM C45,100 μM H2O2 and 256 μM ABTS in buffer yielded v0/[E]0 
values of 0.6 s-1 for the dimer peak and 1.2 s-1 for the monomer. This would suggest 
that the dimer has less catalytic activity than the monomer. This is different from the 
results showing the concentration dependence of v0/[E]0 on the enzyme concentration 
(Figure 5.3), which showed higher concentrations of C45 to be disproportionately 
more active, suggesting the dimer is more catalytically active than the monomer. This 
clearly needs more investigation, however, as the monomer and dimer were extremely 
poorly separated, no repeats of this were performed and only one measurement at a 





Figure 5.24: Rate of ABTS oxidation by the suspected dimer and monomer of C45. 
Reaction between 500 nM of C45 from peak 1 (suspected dimer) and peak 2 (suspected monomer) from 
size exclusion chromatography, 100 μM H2O2 and 256 μM ABTS in aqueous solution. 
 
5.3. Discussion 
In the previous chapters, the generally observed trend was a decrease in structural 
stability and especially catalytic activity of C45 upon the addition of cosolvents. The 
notable exception was TFE, which yielded a significant increase in catalytic activity of 
C45, especially at the highest cosolvent concentration measured (80%). In this 
chapter, this intriguing behaviour is further probed.  
A 4-fold increase in kcat/KMa/KMb was estimated (from 5.8 × 106 M-1 M-1 s-1 in buffer 
to 2.1 × 107 M-1 M-1 s-1 in 80% TFE). The kcat measured in buffer was 890 ± 60 s-1, with 
a KM of 220 ± 30 mM for peroxide. This was not in agreement with literature, where a 
kcat of 1200 s-1 had been determined. Experimental conditions were very similar, the 
only discernible difference being the higher enzyme concentration used in the 
literature research. The good reproducibility of kinetic parameters for C45 between 
different batches ruled out batch to batch variation as a plausible explanation for this 
observation and the concentration dependence of this reaction was probed further. 
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Surprisingly, enzyme concentration was shown to have a significant impact on v0/[E]0, 
a value which is inherently normalised for enzyme concentration and therefore usually 
not affected by this. Here, however, it was shown that a higher enzyme concentration 
yielded higher reaction rates both in buffer and in 80% TFE. With this in mind, the TFE-
induced 7-fold increase in kcat at limiting peroxide concentration measured in chapter 
4 may actually be higher, as this was measured with lower enzyme concentrations to 
allow for the plate reader’s sensitivity limits.  
The reason for this effect was proposed to be a difference in catalytic activity 
between the monomer and dimer of C45. SEC-SAXS and analytical SEC results have 
confirmed the presence of both species in C45. This does not seem to be affected by 
the presence of TFE. Curiously, when the kinetics of monomer and dimer were 
analysed after separation by analytical SEC, the monomer appeared to produce a 
reaction rate twice that of the dimer. This does not agree with the observation that in 
higher C45 concentrations, which are likely to shift the monomer-dimer equilibrium 
closer to the dimer, the highest v0/[E]0 values were observed. However, resolution of 
monomer and dimer peak by analytical SEC was very poor and no repeat 
measurements for this were performed. This raises suspicions that the observed 
increased catalytic activity of the monomer may be an erroneous measurement.  
Furthermore, the mechanism of compound I formation was investigated. As ABTS 
is not involved in this step, the reaction between peroxide and C45 was performed 
both in 80% TFE and in buffer and fit to a double exponential (or in the case of TFE, 
triple exponential, due to the mixing of TFE with water). Kinetic isotope effects as well 
as comparison with unpublished EPR spectroscopy results confirmed that the first 
observed reaction phase was the formation of compound I, which involves breakage 
of an O-H bond. Especially due to the lack of a distal histidine in C45, which is common 
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in natural peroxidases and assists in this proton shuffling process, this step is likely to 
be rate-determining in the catalytic cycle of C45. In 80% TFE, this was shown to be 
significantly faster, suggesting that the cosolvent stabilises compound I. 
The lack of an effect of TFE on the formation of a metallocarbenoid supports the 
hypothesis that the catalytic improvements seen in peroxidase kinetics were related 
to stabilisation of an intermediate of that reaction mechanism as opposed to 
stabilisation of C45. 
Initially the inactivation of HRP by TFE concentrations above 30% may appear to 
be in conflict with the hypothesised stabilisation of compound I by TFE. However, HRP 
has a more complex structure (Figure 1.14) than the almost exclusively α-helical C45. 
Non-helical structural elements may be perturbed by the propensity of TFE to increase 
helicity. Furthermore, HRP requires a greater degree of conformational flexibility to 
bind hydrogen peroxide. Therefore, the hypothesis that TFE stabilises compound I is 
not invalidated by the inactivation of HRP in high concentrations of the cosolvent.  
This chapter built on the previously observed increase in structural stability and 
catalytic activity of C45 in 80% TFE and explored the cosolvent’s effect further. Both 
effects could be confirmed and it appears that the primary cause for the increase in 
catalytic activity is not the observed stabilisation of the enzyme’s native state – which 
was in agreement with the literature (3, 5) – but the stabilisation of the radical 
intermediate compound I. 
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6. Conclusions
The field of enzyme engineering has picked up momentum over the past decade, 
with tailor-made proteins making up ground on their highly evolved natural 
counterparts (304, 305). Many enzymes have been created by directed evolution of 
their natural counterparts. This approach, however, limits the proportion of sequence 
space open to exploration drastically (1). De novo protein design, which has also made 
impressive advances in recent years (1, 306), allows the researcher more freedom. 
The maquette method has brought about some de novo enzymes with a range of 
functionalities (2, 19, 21, 220). This method involves the rational design of simplistic 
four-helix bundle proteins that are complemented with a cofactor. C45, a proficient 
peroxidase that is highly thermostable and has recently also been shown to be able to 
act as a carbene transferase (2, 220), has been designed this way. Little is known, 
however, about the enzyme’s solvent tolerance. In perspective of the wide interest in 
non-aqueous enzymology (7), this work addresses the question whether the versatility 
of maquette enzymes in general, and C45 in particular, is also mirrored in its ability to 
carry out catalysis in organic cosolvents. 
In this work, it has been shown that C45 remains active and stable in some organic 
cosolvents: In the four alcohols tested, including methanol, ethanol, isopropanol and 
the halogenated TFE, as well as acetonitrile, C45 maintained some catalytic activity in 
up to 20% isopropanol, 60% acetonitrile, 70% ethanol and 80% methanol. Generally, 
increasing cosolvent concentrations, and the concomitant increase in hydrophobicity, 
led to decreases in catalytic activity. Surprisingly, addition of TFE followed a different 
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trend and raised the kcat of the reaction between C45, ABTS and hydrogen peroxide 
(under limiting peroxide concentration) by up to 7-fold at 80% TFE, the highest 
cosolvent concentration tested. Furthermore, the total turnover number was enhanced 
by a factor of 34.  
It was particularly surprising that the largest increase in enzymatic activity was 
observed at such a high TFE concentration. TFE had previously been shown to 
improve the catalytic activity of peroxidases (6), but only at lower concentrations. 
Generally, TFE has the ability to stabilise and increase the helicity of proteins (3, 4), 
which is particularly relevant to C45. This effect is most likely caused by enhanced 
intra-protein hydrogen bonds, which can particularly stabilise helical folds (5). In 
agreement with this, CD and NMR spectroscopy did suggest an increase in helicity in 
C45 after addition of TFE. Nonetheless, the ability of TFE to increase helix stability of 
proteins (3) is not necessarily beneficial to all enzymes. Enzymes which are not 
predominantly α-helical, such as horseradish peroxidase, may experience a decrease 
in catalytic activity in high concentrations of TFE which was clearly observed here. 
The positive effect of TFE on catalytic activity has mostly been attributed to the 
stabilisation of the highly reactive compound I, the formation of which proceeds 
significantly faster in TFE. The large increase in total turnover numbers in 80% TFE 
adds weight to the hypothesis that TFE stabilises compound I. This is further 
corroborated by the lack of any discernible effect of TFE on the rate of 
metallocarbenoid formation. This further, recently discovered, function of C45 does 
not involve peroxide mediated compound I formation (220). The observation that the 
presence of TFE did not affect the rate of this suggests that the main effect of TFE on 
the peroxidase kinetics of C45 is related to the stabilisation of compound I, rather than 
a generic structural effect on the enzyme. 
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Furthermore, it was discovered that both in 80% TFE and in buffer, v0/[E]0 was 
surprisingly not independent of the enzyme concentrations, as is usually the case. 
Activity was larger at higher enzyme concentrations. This likely suggests that 
oligomerisation of the enzyme, which is generally concentration dependent, has an 
effect on catalytic activity. Analytical SEC and SEC-SAXS results both confirm the 
presence of a dimer and monomer in C45 solutions. Thus, the increase in v0/[E]0 with 
increasing C45 concentrations suggests that the dimeric form of the enzyme may have 
a higher catalytic activity. It is worth noting that the presence of dimer and monomer 
was demonstrated both in buffer and 80% TFE and the cosolvent surprisingly did not 
have any significant effect on the relative proportions of these species. 
Overall, TFE has shown some unforeseen effects on the peroxidase kinetics of 
C45. With the impressive beneficial effect TFE has as a cosolvent, it would be 
interesting to observe whether this could be further enhanced. For instance, catalysis 
by C45 may conceivably be even more enhanced in neat TFE. Here, an increase from 
70% to 80% TFE concentration almost doubled the kcat at limiting peroxide 
concentration (from 2.6 ± 0.4 s-1 to 5.1 ± 0.4 s-1). This does suggest that a further rise 
in TFE concentration may yield even more impressive raises in catalytic activity. A 
continuation of this work could begin with the analysis of C45 in higher TFE 
concentrations, as well as other helix-stabilising solvents such as 
hexafluoroisopropanol (HFIP), another halogenated alcohol (307). 
A further avenue of interest would be the investigation of the resilience of C45 to 
a mixture of hostile conditions. The enzyme has previously been shown to be 
catalytically active up to temperatures of at least 70 °C (2), in fact significantly more 
so than at room temperature. With the strong stabilising effect of TFE on the enzyme, 
it would be interesting to observe whether the enzyme remains active at even higher 
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temperatures. With the positive effect high temperatures generally have on reaction 
rates, the catalytic activity of C45 may even increase in higher temperatures, if 
thermostability of the enzyme can be achieved. It would be particularly interesting to 
see the difference in total turnover numbers when the enzyme is used in 80% TFE at 
high temperatures. It is possible that an increase in temperatures would be a trade-off 
between rising reaction rates and declining total turnover, even in the presence of TFE. 
Further, the effects of high-pressure environments are worth exploring for the enzyme 
in buffer as well as TFE. This could lay the foundation for new applications of maquette 
enzymes in industry. High-pressure environments, which have been shown to lead to 
dissociation of oligomeric proteins (308, 309), may also provide an interesting route to 
further investigate the difference in catalytic activity between dimer and monomer. Of 
course, with the growing maquette family and the opportunities for enzyme 
optimisation that directed evolution and computational methods have provided, the 
effect of TFE could be investigated on other helical enzymes, for example multi-heme 
enzymes. 
This thesis could provide the basis for a new generation of highly resilient enzymes 
tailor-made for non-aqueous catalysis. This could not only lead to expanded 
applications of peroxidases, for instance in pollutant removal (310), but also fulfil an 
important industrial need.  
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7. Appendix
7.1. C45 and ABTS batch to batch testing 
For kinetic measurements of C45, different batches of both the enzyme and its 
substrate ABTS were compared to ensure results obtained using different batches 
were comparable. A series of experiments was conducted measuring the rate of 
formation of ABTS•+ in buffer at 25 °C. Table 7.1 outlines which batches of enzyme 
and substrate were used for which experiment in the series. 
Table 7.1: Table highlighting which batches of C45 and ABTS were used in which kinetic assay experiment 
in buffer for batch to batch comparisons for C45 and ABTS.. 
Expt. C45 ABTS 
BF252 Batch 2 Batch 1 
BF253 Batch 2 Batch 2 
BF255 Batch 3 Batch 2 
BF256 Batch 3 Batch 1 
BF258 Batch 1 Batch 2 
During each experiment, four repeat measurements were performed and 
averaged. The initial rates for these experiments are shown in  Table 7.2.  
Table 7.2: ABTS•+ formation in buffer for different batches of C45 and ABTS. 
Rate of the oxidation in s-1 of 0.1 - 256 μM ABTS by 100 nM C45 and 100 μM H2O2 at 25 °C in aqueous 
solution using different batches of enzyme and substrate as outlined in  
Table 7.1.   
[ABTS] 
(μM) BF252 BF253 BF255 BF256 BF258 Average 
8 0.0453 -- 0.08152 0.0747 0.05208 0.06 ± 0.02 
16 0.2061 0.23098 0.40082 0.2083 0.33741 0.28 ± 0.09 
32 0.4529 0.4837 0.56205 0.4429 0.47826 0.48 ± 0.05 
64 0.6238 0.65606 0.59291 0.7328 0.65082 0.65 ± 0.06 
128 0.6082 0.64587 0.60527 0.6744 0.62177 0.63 ± 0.03 
256 0.5694 0.6601 0.58386 0.7047 0.62807 0.63 ± 0.06 
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Rates were plotted using Origin software and fitted to Michaelis-Menten kinetics. 
Kinetic parameters for the different experiments are shown in Table 7.3, which shows 
that different batches of substrate and enzyme do not have significantly different 
kinetic properties and are thus comparable. For any further analysis or comparison 
within this work, the average values of these parameters were used as the parameters 
of ABTS oxidation of C45 in buffer.  
Table 7.3: Kinetics of ABTS•+ formation in buffer for different batches of C45 and ABTS. 
kcat (s-1), KM (μM), kcat/KM (s-1 μM-1) as calculated by the origin software for different experiments showing 
no significant difference in kcat for different batches of enzyme and substrate. Different batches of enzyme 
and substrate were used as outlined in  
Table 7.1. 
  kcat (s-1) KM (μM) kcat/KM (s-1 μM-1) 
 
BF252 0.7 ± 0.2 28 ± 15 0.026 
BF253 0.77 ± 0.09 20 ± 10 0.034 
BF255 0.69 ± 0.09 15 ± 8 0.045 
BF256 0.9 ± 0.2 33 ± 16 0.026 
BF258 0.7 ± 0.1 22 ± 10 0.033 
Average 0.76 ± 0.07 24 ± 7 0.033 ± 0.08 
 
Finally, total turnover numbers were calculated for the different experiments 
(Table 7.4). Again, no significant differences can be seen between the batches. 
Table 7.4: Total turnover numbers for kinetic assays of different batches of C45 and ABTS. 
No significant differences can be seen between the total turnover of experiments using different batches 
of substrate and enzyme, as outlined in  
Table 7.1. 
[ABTS] 
(μM) BF252 BF253 BF255 BF256 BF258 Average 
4 2.8125 3.22011 2.67663 2.93478 2.59511 2.8 ± 0.3 
8 4.23913 4.4837 3.84511 4.44293 3.79076 4.2 ± 0.4 
16 5.58424 5.70652 5.91033 5.54348 5.54348 5.7 ± 0.2 
32 9.11685 9.07609 10.8696 8.92663 9.2663 9.5 ± 0.8 
64 25.9783 25.6522 27.6495 25.0815 27.962 26 ± 2 
128 40 39.4565 43.4647 42.1467 44.2391 42 ± 2 
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